-37950312441	<div>The <b>zona {{c1::fasciculata}}</b> secretes <b>{{c2::glucocorticoids}}</b>, such as {{c2::cortisol}}</div>	"<font color=""#fc02ff""><u>G</u>o <u>F</u>ind <u>R</u>ex, <u>M</u>ake <u>G</u>ood <u>S</u>ex</font><div><img src=""paste-496584118763793.jpg"" /></div>"					"<img src=""tmp6C4GVG.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpMzaGH7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::anatomy #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Costanzo::unorganized #AK_Step1::Endocrine::Physiology
-37950302146	<div>The <b>zona {{c2::reticularis}}</b> secretes <b>{{c1::androgens}}</b>, such as dehydroepiandrosterone (DHEA) and androstenedione</div>	"<u>G</u>o <u>F</u>ind <u>R</u>ex, <u>M</u>ake <u>G</u>ood <u>S</u>ex<div><img src=""paste-496584118763793.jpg"" /></div>"					"<img src=""tmp6C4GVG.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpMzaGH7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::anatomy #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Costanzo::unorganized #AK_Step1::Endocrine::Physiology
-37950253036	<div>What is the <b>rate-limiting enzyme</b> in the biosynthesis of <i>adrenocortical</i> hormones?</div><div><br></div><div>{{c1::Cholesterol desmolase}}</div>	- lack of this enzyme leads to absent steroid hormone synthesis; complete enzyme deficiency is lethal due to absent placental progesterone synthesis					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#B&B::Endocrinology::04_Reproductive::03_Female_Reproductive_Hormones #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37950243734	<div>The <i>major</i> <b>glucocorticoid</b> produced in humans is {{c1::<b>cortisol</b> (hydrocortisone)}}</div>						"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::$AnKingUpdates::#Zanki::NotDoing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Costanzo::unorganized #AK_Step1::Endocrine::Physiology
-37950233108	<div>The <i>major</i> <b>mineralocorticoid</b> produced in humans is <b>{{c1::aldosterone}}</b></div>						"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::$AnKingUpdates::#Zanki::NotDoing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Costanzo::unorganized #AK_Step1::Endocrine::Physiology
-37950223968	<div><div>The <u>first</u> step in <i>all</i> pathways of <b>adrenocortical hormone synthesis</b> is the conversion of <b>{{c1::cholesterol}}</b> to <b>{{c1::pregnenolone}}</b> by the enzyme <i>{{c2::<b>cholesterol</b> <b>desmolase</b>}} </i></div></div>	"<i>thus, all layers of the adrenal cortex contain cholesterol desmolase; this enzyme is inhibited by ketoconazole and stimulated by ACTH</i><div><img src=""paste-496725852684881.jpg"" /></div>"					"<img src=""tmplR4nMJ.png""><br/>"	"<div><img src=""paste-122062970553400.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37950107334	<div><b>Pregnenolone</b> may be converted to <b>{{c1::progesterone}}</b> via the enzyme <b><i>{{c2::3β-hydroxysteroid dehydrogenase}}</i></b></div>	"<i>this step may occur in all three pathways (glucocorticoid, mineralocorticoid, or androgen)</i><div><img src=""paste-496721557717585.jpg"" /></div>"					"<img src=""tmplR4nMJ.png""><br/>"	"<img src=""paste-122166049768504.jpg"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37950064321	<div><b>Progesterone</b> may be converted to <b>{{c1::11-deoxycorticosterone (DOC)}}</b> via the enzyme {{c2::<b><i>21</i></b><i><b>β-hydroxylase</b></i>}}</div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"	"<div><img src=""paste-122324963558456.jpg""></div><img src=""paste-122299193754680.jpg"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37950037594	<div><b>11-deoxycorticosterone (DOC)</b> may be converted to <b>{{c1::corticosterone}}</b> via the enzyme {{c2::<b><i>11</i></b><i><b>β-hydroxylase</b></i>}}</div>	"<i>corticosterone has both glucocorticoid and mineralocorticoid activity</i><div><img src=""paste-496721557717585.jpg"" /></div>"					"<img src=""tmplR4nMJ.png""><br/>"	"<img src=""paste-122423747806264.jpg""><img src=""paste-122513942119480.jpg"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949997349	<div><b>Corticosterone</b> may be converted to <b>{{c1::aldosterone}}</b> via the enzyme <b><i>{{c2::aldosterone synthase}}</i></b></div>	"<i>aldosterone synthase is stimulated by angiotensin II</i><div><img src=""paste-496721557717585.jpg""></div>"					"<img src=""tmplR4nMJ.png""><br/>"	"<img src=""paste-122629906236472.jpg"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949969095	<div>The <b>zona {{c2::glomerulosa}}</b> normally <i>cannot</i> produce</div><div> <b>glucocorticoids</b> because it lacks the enzyme <b><i>{{c1::17α-hydroxylase}}</i></b></div>	<i>also because corticosterone (a weak glucocorticoid) is converted to aldosterone in the presence of aldosterone synthase</i>					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949945339	<div>Can <b>mineralocorticoids</b> still be produced if the mineralocorticoid pathway is blocked <i>below the level</i> of <b>DOC</b> (i.e. absence of <i>11β-hydroxylase</i> or <i>aldosterone synthase</i>)?</div><div><br /></div><div>{{c1::Yes, 11-deoxycorticosterone (DOC) and corticosterone both have mineralocorticoid activity}}</div><div></div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949868403	<div>Can <b>mineralocorticoids</b> still be produced if the mineralocorticoid pathway is blocked <i>above the level</i> of <b>DOC</b> (i.e. absence of 21<i>β-hydroxylase</i>)?</div><div><br /></div><div>{{c1::No}}</div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949841857	<div><div><b>Pregnenolone </b>may be converted to <b>{{c1::17-hydroxypregnenolone}}</b> via the enzyme <b><i>{{c2::17α-hydroxylase}} </i></b></div></div>	"<div><div><i>this step may occur in the glucocorticoid and androgen pathway ONLY</i></div></div><div><i><img src=""paste-496721557717585.jpg"" /></i></div>"					"<img src=""tmplR4nMJ.png""><br/>"	"<div><div><img src=""paste-123128122442808.jpg""></div></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949811664	<div><b>Progesterone</b> may be converted to <b>{{c1::17-hydroxyprogesterone}}</b> via the enzyme <i><b>{{c2::17α-hydroxylase}}</b></i></div>	"<div><i>this step may occur in the glucocorticoid and androgen pathway ONLY</i></div><div><i><img src=""paste-496721557717585.jpg"" /></i></div>"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949789459	<div><b>17-hydroxypregnenolone</b> may be converted to <b>{{c1::17-hydroxyprogesterone}}</b> via the enzyme <i><b>{{c2::3β-hydroxysteroid dehydrogenase}}</b></i></div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"	"<div><img src=""paste-123188251984952.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949767071	<div><b>17-hydroxyprogesterone</b> may be converted to <b>{{c1::11-deoxycortisol}}</b> via the enzyme <b>{{c2::21<i>β-hydroxylase</i>}}</b></div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"	"<div><img src=""paste-123403000349752.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949735019	<div><b>11-deoxycortisol</b> may be converted to <b>{{c1::cortisol}}</b> via the enzyme {{c2::<b>11</b><i><b>β-hydroxylase</b></i>}}</div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"	"<div><img src=""paste-123467424859192.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949678656	<div>Can <b>glucocorticosteroids</b> still be produced if there is absence of <i>17α-hydroxylase</i>?</div><div><br /></div><div>{{c1::Yes, the zona fasciculata can still produce <u>corticosterone</u>, which has glucocorticoid activity}}</div>	"<div><i>corticosterone has both mineralocorticoid and glucocorticoid activity</i></div><img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949615981	<div>Can <b>glucocorticosteroids</b> still be produced if there is absence of <i>cholesterol desmolase</i>, <i>21β-hydroxylase</i>, <i>11β-hydroxylase</i>, or <i>3β-hydroxysteroid dehydrogenase</i>? </div><div><br /></div><div>{{c1::No, a lack of any of these enzymes would block the synthesis of <u>both</u> corticosterone AND cortisol}}</div>	"<div><i>death will ensue without appropriate hormone replacement therapy</i></div><div><i><img src=""paste-496721557717585.jpg"" /></i></div>"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949593940	<div><b>17-hydroxypregnenolone </b>may be converted to {{c1::<b>dehydroepiandrosterone</b> (DHEA)}} via the enzyme <b><i>{{c2::17,20-lyase}}</i></b></div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"	"<img src=""paste-123716532962360.jpg"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949555147	<div><b>17-hydroxyprogesterone</b> may be converted to <b>{{c1::androstenedione}}</b> via the enzyme <b><i>{{c2::17,20-lyase}}</i></b></div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png"" /><br />"	"<div><img src=""paste-123733712831544.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949541851	<div><b>Dehydroepiandrosterone</b> (DHEA) may be converted to <b>{{c1::androstenedione}}</b> via the enzyme {{c2::<b><i>3β-hydroxysteroid dehydrogenase</i></b>}}</div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949522944	<div><b>Adrenal {{c1::androgens}}</b>, such as DHEA and androstenedione, have a <b>{{c2::ketone}}</b> group at C-17 and are excreted as <b>{{c3::17-ketosteroids}}</b> in the {{c4::urine}}</div>						"<img src=""tmplR4nMJ.png""><br/>"	"<img src=""paste-123841087013944.jpg"" />"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949496428	<div>Which enzyme is unique to the <b>zona glomerulosa</b> and thus the <b>mineralocorticoid</b> synthesis pathway?</div><div><br></div><div><i>{{c1::Aldosterone synthase}}</i></div>	"<img src=""paste-496721557717585.jpg"">"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949484302	<div>Which enzymes (2) are unique to the <b>zona fasciculata/reticularis</b> and thus the <b>glucocorticoid</b> and <b>androgen </b>synthesis pathways?</div><div><br /></div><div>{{c1::17α-hydroxylase and 17,20-lyase}}</div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949461871	<div><b>{{c1::21}}-carbon steroids</b> include both the mineralocorticoids and glucocorticoids (progesterone, deoxycorticosterone, aldosterone, and cortisol)</div>						"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949450315	<div><b>{{c1::19}}-carbon steroids</b>, such as DHEA and androstenedione, have <b>{{c2::androgenic}} activity</b> and are precursors to <b>{{c1::estrogen}}</b></div>						"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949434429	<div><b>{{c1::18}}-carbon steroids</b> have <b>{{c2::estrogenic}} activity</b></div>	<i>aromatization occurs in the ovaries and placenta, producing estrogen</i>					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37949421913	<div><b>{{c1::Metyrapone}}</b> is a drug that inhibits <b>glucocorticoid</b> <b>biosynthesis</b> via inhibition of the enzyme <i><b>{{c2::11β-hydroxylase}}</b></i></div>	"Metyrapone stimulation test is useful for diagnosis of which order of <u>adrenal insufficiency</u> a patient with symptoms is experiencing<div>- if 1* = decreased 11-deoxycortisol, increased ACTH</div><div>- if 2*/3* = decreased 11-deoxycortisol, decreased ACTH</div><div><br /></div><div><img src=""paste-18846316494849.jpg"" /></div>"					"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37949397625	<b>{{c1::Ketoconazole}}</b> is a drug that inhibits <b>glucocorticoid</b> <b>biosynthesis</b> via inhibition of the enzyme <i><b>{{c2::cholesterol desmolase}}</b></i>						"<img src=""tmplR4nMJ.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::synthesis #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37948659626	<div><b>Glucocorticoid </b>(cortisol) <b>secretion</b> is <b>{{c1::pulsatile}}</b> and <b>{{c1::diurnal}}</b> (daily) in nature, oscillating with a <b>circadian rhythm</b></div>	"<div><i>this is a result of the diurnal pattern of CRH and ACTH secretion; diurnal pattern may be lost by coma, blindness, or constant exposure to dark/light -- aldosterone follows a similar secretion pattern </i></div><div><img src=""paste-501927058080001.jpg"" /><i> </i></div>"					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946902190	<div><b>Cortisol</b> levels are <i>highest</i> just before <b>{{c1::awakening}}</b> and <i>lowest</i> in the <b>{{c1::evening}}</b> </div>	"<div><i>in a person that wakes in the morning and sleeps at night</i></div><img src=""paste-501922763112705.jpg"" />"					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946873395	<div><b>Corticotropin-releasing hormone</b> (CRH) is secreted by cells of the <b>{{c1::paraventricular}}</b> <b>nuclei</b> of the hypothalamus </div>	<i>it reaches the anterior pituitary via the hypothalamic-hypophysial portal blood</i> 					"<img src=""tmp5sDZF8.png""><br/>"		"<b>Other:</b><br> <img src=""tmp_ot7OC.png"" />"	#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Neurology::02_Structures::08_Thalamus_Hypothalamus_Limbic #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S01_Introduction_to_Endocrinology #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946855909	<div><div>Through which <u>secondary messenger(s)</u> does <b>CRH</b> exert its actions on the anterior pituitary?</div><div><br /></div><div>{{c1::cAMP}}</div></div>	<i>FLAT <b>C</b>hAMP</i>					"<img src=""paste-e2094f6424beb4a748ecbd59273e780c682eebbe.jpg""><div><img src=""tmp5sDZF8.png""><br></div>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Endocrinology::05_Other_Topics::01_Pituitary_Gland #AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946852145	<div><b>Corticotropin-releasing hormone (CRH)</b> binds to <b>corticotrophs</b> on the anterior pituitary, directing them to <i>synthesize</i> <b>{{c2::POMC}}</b> and <i>secrete</i> <b>{{c2::ACTH}}</b> </div>	"<div><i>POMC is the precursor to ACTH</i></div><img src=""paste-501948532916579.jpg"" />"					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S01_Introduction_to_Endocrinology #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946828340	<div>Which zones of the <b>adrenal</b> <b>cortex</b> does <b>ACTH</b> act on to <i>increase</i> steroid hormone synthesis? </div><div><br></div><div>{{c1::All three zones :)}}</div>	but mostly the zona fasciculata								#AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946751152	<div><b>ACTH</b> increases steroid hormone synthesis via stimulation of the enzyme {{c1::<b>cholesterol</b> <b>desmolase</b>}}, thus increasing the conversion of <b>cholesterol</b> to <b>pregnenolone</b> </div>						"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946729190	<div><i>Long-term</i> effects of <b>ACTH</b> include {{c1::up-regulation}} of <b>ACTH</b> <b>receptors</b>, thus {{c1::increasing}} the <b>sensitivity</b> of the <b>adrenal</b> <b>cortex</b></div>						"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946701807	<div>Chronically <i>elevated</i> levels of <b>ACTH</b> cause {{c1::hypertrophy/hyperplasia}} of the <b>adrenal cortex</b></div>						"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946685618	<div><div>Through which <u>secondary messenger(s)</u> does <b>ACTH</b> exert its actions on the adrenal cortex?</div><div><br /></div><div>{{c1::cAMP}}</div></div><div><br /></div><div><br /></div>						"<img src=""paste-e2094f6424beb4a748ecbd59273e780c682eebbe.jpg""><div><img src=""tmp5sDZF8.png""><br></div>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946682215	<div>How does <b>cortisol</b> affect secretion of <b>CRH</b> from the hypothalamus?</div><div><br /></div><div>{{c1::inhibits secretion, <i>both </i>directly and indirectly}}</div>	"<div><i>indirectly via affecting the hippocampal neurons which synapse on the hypothalamus</i></div><div><i><img src=""paste-501944237949283.jpg""></i></div>"					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S01_Introduction_to_Endocrinology #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946668569	<div>How does <b>cortisol</b> affect secretion of <b>ACTH</b> from the anterior pituitary? </div><div><br></div><div>{{c1::Inhibits secretion, <i>directly</i>}}</div>	"<img src=""paste-501944237949283.jpg"" />"					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S01_Introduction_to_Endocrinology #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946658095	<div>Chronic <i>excess</i> levels of <b>cortisol</b> (glucocorticoid) result in decreased levels of <b>{{c1::CRH}}</b> and <b>{{c1::ACTH}}</b> via negative feedback</div>	"<img src=""paste-501948532916579.jpg"" />"					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S01_Introduction_to_Endocrinology #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946623710	<div><b>{{c2::Dexamethasone}}</b> is a synthetic <b>{{c1::glucocorticoid}}</b> that mimics the actions of cortisol, including <i>suppression of ACTH</i></div>						"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946607222	<div>The <b>{{c1::dexamethasone}} </b><b>suppression </b><b>test</b> is useful in patients with <b>{{c2::hypercortisolism}}</b><i> </i></div>	<i>helps distinguish possibly etiologies (i.e. ACTH-secreting tumor versus adrenal cortical tumor; Cushing syndrome vs disease)</i>					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946575008	<div>What is the result of the <b>dexamethasone suppression test</b> in a <i>normal</i> patient?</div><div><br /></div><div>{{c1::<u>Low-dose</u> dexamethasone inhibits ACTH secretion and consequently cortisol secretion}}</div>						"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946562008	<div>What is the result of a <b>dexamethasone suppression test</b> if the cause of <b>hypercortisolism</b> is an <b>ACTH-secreting tumor</b> of the <u>anterior pituitary</u>?</div><div><br /></div><div>{{c1::<i>LOW</i> dose of dexamethasone does not suppress cortisol secretion, but <i>HIGH</i> dose does}}</div>	<i>the tumors ACTH secretion is less sensitive to negative feedback</i>					"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946544147	<div>What is the result of a <b>dexamethasone suppression test</b> if the cause of <b>hypercortisolism</b> is an <b>adrenal cortical tumor</b>?</div><div><br /></div><div>{{c1::<u>neither</u> low <i>nor</i> high dose dexamethasone suppresses cortisol secretion}} </div>						"<img src=""tmp5sDZF8.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37946520347	<div>What is the effect of <b>somatostatin </b>and <b>opioids</b> on <b>ACTH secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>	"<img src=""paste-501961417818362.jpg"" />"					"<img src=""tmp5sDZF8.png"" /><br />"			#AK_Step1::#FirstAid::endo::phys::adrenal::regulation::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945647727	<b>{{c1::Aldosterone}} secretion</b> (from the zona glomerulosa) is under <b><i>tonic</i></b>, but not exclusive, control by <b>ACTH</b><div><b><br /></b></div>	<i>i.e. ACTH is still an essential first step in the secretion of aldosterone</i>					"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945302159	<div>The primary regulation of <b>aldosterone</b> secretion occurs through changes in <b>{{c1::ECF volume}}</b> (via the <b>{{c2::renin-angiotensin II-aldosterone}}</b> <b>system</b>) and changes in serum <b>{{c1::potassium}}</b> levels </div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Cardiology::08_Hypertension::02_Secondary_Hypertension #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#B&B::Renal::03_Electrolytes::02_Sodium_Water_Balance #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945228704	<div>Decreases in <b>{{c2::ECF volume}}</b> (e.g. hemorrhage or decreased Na<sup>+</sup>) cause a decrease in <b>renal</b> <b>perfusion</b> <b>pressure</b>, which in turn increases <b>secretion</b> of the enzyme <b>{{c1::renin}}</b></div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#B&B::Renal::03_Electrolytes::02_Sodium_Water_Balance #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945202010	<div><b>{{c1::Renin}}</b>, an enzyme, catalyzes the conversion of <b>{{c2::angiotensinogen}}</b> to <b>{{c2::angiotensin I}}</b></div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945191086	<div><b>{{c2::Angiotensin I}}</b> is converted to <b>{{c2::angiotensin II}}</b> by the enzyme <b>{{c1::angiotensin-converting enzyme (ACE)}}</b></div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945174517	<div><b>{{c1::Angiotensin II}}</b> acts on the zona glomerulosa to <i>stimulate</i> <u>aldosterone synthesis</u> via increased activity of the enzyme <b>{{c2::aldosterone synthase}}</b></div>	<i>thus increased conversion of corticosterone to aldosterone </i>					"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945157437	<div><b>{{c1::Aldosterone}}</b> is a hormone that <u>increases</u> <b>renal Na<sup>+</sup> reabsorption</b>, thereby restoring ECF volume and blood volume to normal</div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#B&B::Renal::03_Electrolytes::02_Sodium_Water_Balance #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945142941	<div>To what receptor does <b>angiotensin II</b> bind?</div><div><br /></div><div>{{c1::AT<sub>1</sub> receptor}}</div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945130095	<div>Through which <u>secondary messenger(s)</u> does the angiotensin II-bound <b>AT<sub>1</sub> receptor </b>propagate its signal?</div><div><br /></div><div>{{c1::IP<sub>3</sub>/Ca<sup>2+</sup>}}</div><div><br /></div><div><br /></div>						"<img src=""tmp0D1cNW.png""><br><div><img src=""paste-e2094f6424beb4a748ecbd59273e780c682eebbe.jpg""><br></div>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37945127092	<div>How does <b>hyperkalemia</b> influence <b>aldosterone secretion</b>?</div><div><br /></div><div>{{c1::Increased aldosterone secretion}}</div>	<i>increased K<sup>+</sup> depolarizes adrenal cells, causing Ca<sup>2+</sup> to flood in, which then stimulates aldosterone synthesis in a similar mechanism to angiotensin II</i>					"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::regulation::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938875965	<div>Glucocorticoids <b>increase </b>{{c1::<b>protein catabolism</b> (proteolysis)}} in muscle and decrease protein synthesis, thereby providing more amino acids to the liver for <b>gluconeogenesis</b></div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938859903	<div><b>Glucocorticoids</b> {{c1::<u>decrease</u>}}<b> glucose </b><b>utilization</b> by tissues and {{c1::<u>decrease</u>}} <b>insulin</b> <b>sensitivity </b>of adipose tissue</div>	<i>diabetogenic effect</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938846964	<div>Do glucocorticoids increase or decrease <b>insulin resistance</b>?</div><div><br /></div><div>{{c1::Increase (by decreasing insulin sensitivity of adipose tissue)}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938840935	<div>Glucocorticoids <b>increase peripheral {{c1::lipolysis}}</b>, which provides more <u>glycerol</u> to the liver for <b>gluconeogenesis</b> </div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938832268	<div>Glucocorticoids are a potent stimulator for <b>{{c1::gluconeogenesis}}</b>, thus they are essential for <b>survival during {{c2::fasting}}</b></div>	<i>overall the effects of glucocorticoids are catabolic and diabetogenic</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938818538	<div>In <b>hypocorticolism</b>, there is <b>decreased</b> {{c1::gluconeogenesis}} and thus <b>hypoglycemia</b>, and vice versa </div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938811912	"<div>Glucocorticoids may have <b>anti-inflammatory </b>effects by inducing the synthesis of <b>{{c1::lipocortin}}</b>, an inhibitor of {{c2::<b>phospholipase A</b><sub style=""font-weight: bold; "">2</sub>}} </div>"	<i>phospholipase A<sub>2</sub> provides the precursor (arachidonic acid) for the synthesis of <b>prostaglandins</b> and <b>leukotrienes</b>, which mediate the immune response</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Pulmonary::02_Obstructive/Restrictive_Diseases::04_Treatment_COPD_Asthma #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938791461	<div>Glucocorticoids may have <b>anti-inflammatory</b> effects by <i>inhibiting</i> the <i>production</i> of <b>{{c1::interleukin-2 (IL-2)}}</b> and thus <i>inhibiting</i> the <b>proliferation of {{c2::T lymphocytes}}</b></div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938748128	<div>Glucocorticoids may have <b>anti-inflammatory </b>effects via the inhibition of the <i>release</i> of <b>{{c1::histamine}}</b> and <b>{{c1::serotonin}}</b> from mast cells and platelets </div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Pathology::06_Inflammation_Principles #AK_Step1::#B&B::Pulmonary::02_Obstructive/Restrictive_Diseases::04_Treatment_COPD_Asthma #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938738228	<div>What is the effect of <b>glucocorticoids</b> on blood <b>neutrophil</b> levels?</div><div><br /></div><div>{{c1::Increased (<u>neutrophilia</u>) due to decreased WBC adhesion}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938728920	<div>Do <b>glucocorticoids</b> cause an increase or decrease in eosinophils?</div><div><br /></div><div>{{c1::Decrease}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938712122	<div>How do glucocorticoids <b>suppress the immune response</b>?</div><div><br></div><div>{{c1::By inhibiting production of IL-2 and subsequent T-cell proliferation}}</div>	<i>in pharmacologic doses, glucocorticoids are used to <b>prevent rejection of transplanted organs</b></i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938696887	<div>Cortisol (glucocorticoids) <b>up-regulates</b> <b>{{c1::α<sub>1</sub>}}</b> <b>receptors</b> on arterioles, increasing their <b>sensitivity</b> to {{c2::catecholamines (i.e. norepinephrine and epinephrine)}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938677302	<div><b>Glucocorticoids</b> (e.g. cortisol) are essential in maintaining {{c1::<b>vascular</b> <b>responsiveness</b>}} to <b>catecholamines</b></div>	<i>via upregulatin of α<sub>1</sub> receptors on arterioles</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938661114	<div>What is the effect of <b>hypocortisolism </b>on <b>blood pressure</b>? </div><div><br /></div><div>{{c1::Decreased (hypotension)}}</div>	<i>secondary to decreased α<sub>1</sub> receptors, which causes decreased vasoconstriction</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"	"<img src=""paste-610327737664556.jpg""><img src=""paste-610211773547564.jpg""><br><img src=""tmp537ggq.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938631640	<div>Glucocorticoids decrease {{c2::<b>bone</b> <b>formation</b>}} by decreasing <b>{{c1::osteoblast}}</b> activity</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938565455	<div>What is the effect of <b>glucocorticoids</b> on <b>fibroblast activity</b>?</div><div><br></div><div>{{c1::Decreased}}</div>	<i>causes striae (stretch marks)</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938555826	<div><b>Cortisol</b> results in a(n) {{c1::increased}} <b>glomerular filtration rate (GFR)</b></div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938550529	<div><b>Cortisol</b> results in {{c1::decreased}} <b>REM sleep</b> and {{c1::increased}} <b>awake time</b></div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938544701	<div><b>Cortisol</b> travels in the blood bound to {{c1::corticosteroid-binding globulin (CBG)}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938540309	<div><i>Exogenous</i> <b>corticosteroids</b> can cause {{c1::<u>candidiasis</u>}} and {{c2::<u>reactivation of TB</u>}} as a result of <b>IL-2 inhibition </b></div>						"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938528470	<div>At high concentrations, <b>cortisol</b> can bind to {{c1::mineralocorticoid (aldosterone)}} <b>receptors</b></div>	<i>cortisol has a high affinity for mineralocorticoid receptors, but is deactivated by the renal <b>enzyme 11β-hydroxysteroid dehydrogenase</b>, thus producing only <b>weak</b> mineralocorticosteroid activity</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::cortisol #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938516762	<div><b>Mineralocorticoids (aldosterone)</b> cause <i>increased</i> renal <b>{{c1::Na<sup>+</sup>}} </b></div><div><b>reabsorption</b> via action on the <b>{{c2::principal}}</b> <b>cells</b> of the late distal tubule and collecting duct</div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::action::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938503828	<div><b>Mineralocorticoids (aldosterone)</b> cause <i>increased</i> renal <b>{{c1::K<sup>+</sup>}}</b></div><div><b> secretion</b> via action on the <b>{{c2::principal}}</b> <b>cells</b> of the late distal tubule and collecting duct</div>						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::action::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938492821	<b>Mineralocorticoids (aldosterone)</b> cause <i>increased</i> renal <b>{{c1::H<sup>+</sup>}} secretion</b> via action on the {{c2::<u>α-intercalated</u>}}<u> cells</u> of the late distal tubule and collecting duct						"<img src=""tmp0D1cNW.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::01_Adrenal_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::05_Nephron_Physiology #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::adrenal::action::aldosterone #AK_Step1::#Physeo::Endocrinology::Physiology::S07_Adrenal_glands #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938485739	In <i>females</i>, the <b>adrenal androgens</b> are responsible for the development of {{c1::pubic and axillary hair}} and for {{c2::libido}}<div><br /></div>	<i>minor role in males because majority of testosterone synthesis is in the testes</i>					"<img src=""tmp4WoJeC.png"" /><br /><img src=""tmplR4nMJ.png"" /><br />"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::androgens #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37938118271	In <b>adrenogenital syndrome</b>, the <u>overproduction</u> of <b>adrenal</b> <b>androgens</b> will result in increased urinary levels of <b>{{c1::17-ketosteroids}}</b> <div><br /></div>	<i>adrenogenital syndrome is another name for congenital adrenal hyperplasia</i>					"<img src=""tmp4WoJeC.png"" /><br /><img src=""tmplR4nMJ.png"" /><br />"			#AK_Step1::#FirstAid::endo::phys::adrenal::action::androgens #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37937883194	<b>{{c2::Addison}} disease</b> is most commonly caused by <b>{{c1::autoimmune destruction}} </b>of <u>all three zones</u> of the adrenal cortex, which causes acute <b>adrenal crisis</b>	<i><div></div></i><i><br />also known as <b>primary</b> <b>adrenocortical</b> <b>insufficiency</b>; primary defect of the adrenal cortex, not of the hypothalamus-hypophysial axis</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<i><div></div></i><img src=""paste-611268335502380.jpg""><br><img src=""tmpqlxMPX.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::primaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933419935	<div>Which classes of steroid hormones are decreased in <b>Addison disease</b>?</div><div><br></div><div>{{c1::All three (glucocorticoids, mineralocorticoids, and androgens)}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""tmpqlxMPX.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::primaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933407581	<div>What is the level of <b>ACTH</b> in <b>Addison disease</b>? Why?</div><div><br /></div><div>{{c1::Increased; low cortisol levels stimulate ACTH secretion by negative feedback}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""paste-612264767915052.jpg"" /><img src=""paste-612591185429548.jpg"" /><br/><img src=""tmpqlxMPX.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::primaryadrenalinsufficiency #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933400593	<div>What effect does <b>Addison disease</b> have on <u>blood sugar levels</u>?</div><div><br /></div><div>{{c1::Hypoglycemia}}</div>	<i>also may cause nausea, weight loss, and weakness</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<div><img src=""paste-570faa433803875d2aa7e0e204ba854e9bfef65a.jpg""><i><br></i><img src=""tmpqlxMPX.png""></div>"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::primaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933369469	<div>One <u>clinical feature</u> of <b>Addison disease</b> is {{c1::hyperkalemia}} (K<sup>+</sup> levels)</div>	<i>due to decreased aldosterone levels</i> 					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""tmpqlxMPX.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::primaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933354791	<div><b>Addison disease</b> may present with <u>decreased</u> {{c1::<b>pubic/axillary hair</b>}} and {{c2::<b>libido</b>}} in females due to <u>decreased</u> levels of {{c3::androgens}} </div>	<i><br /></i>					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<i><img src=""paste-612470926345260.jpg"" /></i><br/><img src=""tmpqlxMPX.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::primaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933326109	<div>What is the<b> treatment</b> of <b>Addison disease</b> (primary adrenocortical insufficiency)?</div><div><br /></div><div>{{c1::Replacement of glucocorticoids and mineralocorticoids}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<br/><img src=""tmpqlxMPX.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::primaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933315010	<div><b>{{c1::Secondary adrenocortical}} </b><b>insufficiency</b> occurs when there is insufficient <b>{{c2::CRH}}</b> (uncommon) or insufficient <b>{{c2::ACTH}}</b></div>	<i>therefore it is a primary defect of the hypothalamus or anterior pituitary, not the adrenal cortex</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""paste-612728624383020.jpg""><br><img src=""tmp537ggq.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::secondaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933285686	<div>Which classes of steroid hormones are <u>decreased</u> in<b> secondary adrenocortical insufficiency</b>?</div><div><br></div><div>{{c1::Glucocorticoids +/- androgens}}</div>	<i>aldosterone only needs low (tonic) levels of ACTH, thus, secondary adrenocortical insufficiency does <u>not</u> present with hyperkalemia, metabolic acidosis, or hypotension</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""tmp537ggq.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::secondaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933241090	<div>What is the level of <b>ACTH</b> in <b>secondary adrenocortical insufficiency</b>? Why?</div><div><br /></div><div>{{c1::Decreased; the disease is a result of decreased ACTH secretion}}</div>	<i>this is an important distinguishing feature from Addison disease and explains why secondary adrenocortical insufficiency does <u>not</u> present with hyperpigmentation</i>					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""paste-612732919350316.jpg""><br><img src=""tmpqlxMPX.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::secondaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933222420	<div><div>How do <u>blood sugar levels</u> change in <b>secondary adrenocortical deficiency</b>? </div><div><br /></div><div>{{c1::Decreased (hypoglycemia)}}</div></div>	<i>due to decreased levels of cortisol</i> 					"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""tmp537ggq.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::secondaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933214304	<div>Does <b>secondary adrenocortical insufficiency</b> present with hyperpigmentation? Why?</div><div><br /></div><div>{{c1::No, ACTH levels are low therefore there is no increased melanocyte-stimulating hormone (MSH)}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""paste-613110876472364.jpg"" /><br/><img src=""tmp537ggq.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::secondaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933205957	<div>Does <b>secondary adrenocortical insufficiency</b> present with any of the following symptoms: hyperkalemia, metabolic acidosis, or hypotension?</div><div><br /></div><div>{{c1::No, aldosterone levels are normal}}</div>						"<img src=""tmp5sDZF8.png"" /><br /><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""paste-613171006014508.jpg"" /><br/><img src=""tmp537ggq.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::secondaryadrenalinsufficiency #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933198856	<div><b>{{c1::Cushing}} syndrome</b> is the result of chronic <b>excess glucocorticoids</b> by: </div><div> 1. Adrenal gland hyperplasia</div><div> 2. {{c2::Pharmacologic doses of glucocorticoids}} (most common)</div><div> 3. ACTH secreting pituitary adenoma (Cushing <i>disease</i>)</div><div> 4. Ectopic ACTH production (e.g. small cell lung carcinoma)</div>						"<img src=""tmp0LqqL6.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#B&B::Pulmonary::03_Other::03_Lung_Cancer #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933154546	<div><b>Cushing </b><b>{{c1::disease}}</b> is the result of chronic <b>excess</b> <b>glucocorticoids</b> caused by {{c2::<i>hypersecretion of ACTH</i> from a <b>pituitary adenoma</b>}}</div>						"<img src=""tmp0LqqL6.png""><br/>"			#AK_Step1::#B&B::Cardiology::08_Hypertension::02_Secondary_Hypertension #AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933133615	<div><div>Which classes of steroid hormones are <u>increased</u> in <b>Cushing syndrome/disease</b>?</div><div><br /></div><div>{{c1::glucocorticoids (cortisol) +/- androgens}}</div></div>						"<img src=""tmp0LqqL6.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933093326	<div><div>What is the level of <b>ACTH</b> in <b>Cushing <i>disease</i></b>? Why?</div></div><div><br /></div><div>{{c1::Increased because the disease is caused by an ACTH-secreting tumor}}</div>						"<img src=""tmp0LqqL6.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933043579	<div>What <u>clinical features</u> are seen in <b>Cushing syndrome/disease</b> that are a result of <b>increased androgen levels</b>:</div><div><br></div><div>{{c1::Virilization}} (in women)</div>	<i><br /></i>					"<img src=""tmp0LqqL6.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933021099	"<div><div>What would the result of a <b>dexamethasone suppression test</b> be in a patient with <b>Cushing </b><i style=""font-weight: bold; "">disease</i>? </div><div><br></div><div>{{c1::Cortisol response WOULD BE suppressed by <i>high</i> dose dexamethasone}}</div></div>"						"<img src=""tmp0LqqL6.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37933014626	"<div>What is a possible treatment for <b>Cushing </b><i style=""font-weight: bold; "">syndrome</i>? </div><div><br /></div><div><b>{{c1::Ketoconazole}}</b> or <b>{{c1::metyrapone}}</b>, which block steroid hormone biosynthesis</div>"						"<img src=""tmp0LqqL6.png""><br/>"	"<img src=""paste-b0fbeb439fcafbdc95ddaea8305d78f7a2b92018.jpg""><div><img src=""paste-4b5cda3982c52af010700e5f2e749e0991666385.jpg""><br></div><div><img src=""paste-0cb9ee898be80ce4b461f771e6a19097bfe57199.jpg""><br></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932982601	"<div>What is the treatment for <b>Cushing </b><i style=""font-weight: bold; "">disease</i>?</div><div><br /></div><div>{{c1::Removal of the ACTH-secreting tumor}}</div>"						"<img src=""tmp0LqqL6.png""><br/>"			#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::cushing #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932976539	<div><b>{{c1::Conn}} syndrome</b>, or <b>primary hyperaldosteronism</b>, is caused by an <b>{{c2::aldosterone-secreting tumor}}</b></div>						"<img src=""tmpEHV7SI.png""><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""paste-151565100909624.jpg"" /><br/><img src=""tmpRP9enN.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::conn #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932963041	<div><b>Conn syndrome </b>presents with <b>hypertension</b>, <b>hypokalemia</b>, and <b>metabolic alkalosis</b> due to {{c1::increased}} <u>aldosterone</u> levels</div>	<i>also have <b>decreased</b> <b>renin</b> levels; increased ECF volume causes increased renal perfusion pressure, which inhibits renin secretion</i><div><i><br /></i></div><div><i>These electrolyte imbalances may cause <b>paresthesias </b>and <b>muscle weakness </b>in some patients </i></div>					"<img src=""tmpEHV7SI.png""><br/><img src=""tmp0D1cNW.png""><br/>"	"<div><img src=""paste-151998892606520.jpg""><img src=""paste-152200756069432.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#B&B::Renal::02_Acid_Base::04_Metabolic_Alkalosis #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::conn #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37932942496	<div>Treatment of <b>Conn syndrome</b> consists of administration of an {{c1::<u>aldosterone</u>}}<u> antagonist</u>, such as <b>{{c2::spironolactone}}</b>, followed by removal of the aldosterone-secreting tumor</div>						"<img src=""tmpEHV7SI.png""><br/><img src=""tmp0D1cNW.png""><br/>"	"<img src=""paste-153777009067064.jpg""><br><div><img src=""paste-151784144241720.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::03_Adrenal_Disorders #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiology::conn #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932929531	<div><div>Which classes (2) of steroid hormones are <u>decreased</u> in <b>21β-hydroxylase deficiency</b>?</div><div><br></div><div>{{c1::Glucocorticoids and mineralocorticoids}}</div></div>	"<i>causes shunting of the steroid synthesis pathway leading to <b>increased androgen production</b></i><div><i><b><img src=""paste-496721557717585.jpg"" /></b></i></div>"					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Reproductive::07_Other_topics::02_Disorders_Sexual_Developement #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologybeta #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932908416	<div><b>{{c1::21β-hydroxylase}} deficiency</b> is the <i>most common</i> cause of <b>congenital adrenal hyperplasia</b></div>	"<i>belongs to a group of disorders characterized by </i><b style=""font-style: italic; "">adrenogenital syndrome</b> "					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""paste-124450972369976.jpg""><img src=""paste-124214749168696.jpg""><br><img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Reproductive::07_Other_topics::02_Disorders_Sexual_Developement #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologybeta #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932893152	<div>What is the level of <b>ACTH</b> in <b>21β-hydroxylase deficiency</b>? Why?</div><div><br /></div><div>{{c1::Increased, due to decreased feedback inhibition from cortisol}}</div>	<i>leads to <b>adrenocortical hyperplasia</b></i>					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""paste-124446677402680.jpg""><br><img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Reproductive::07_Other_topics::02_Disorders_Sexual_Developement #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologybeta #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932878442	<div>What <u>clinical features</u> are seen in <b>21β-hydroxylase deficiency </b>that are a result of <u>increased</u><b> androgen </b>levels in <b>females</b>? </div><div><br /></div><div>{{c1::Masculinization (<u>clitoral enlargement</u>, early appearance of pubic/axillary hair)}}</div>	"<div><i>other clinical features are those of glucocorticoid and mineralocorticoid deficiency</i></div><div><i><img src=""paste-496721557717585.jpg"" /></i></div>"					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<div><i><img src=""paste-124210454201400.jpg""></i><br></div><img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#B&B::Reproductive::07_Other_topics::02_Disorders_Sexual_Developement #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologybeta #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932835000	<div>In <b>21β-hydroxylase deficiency</b>, there is an increased level of<b> urinary {{c1::17-ketosteroids}}</b></div>						"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<br/><img src=""tmpXBatir.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologybeta #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932824544	<div>What is the treatment for <b>21β-hydroxylase deficiency</b>?</div><div><br /></div><div>{{c1::Replacement therapy of both glucocorticoids and mineralocorticoids}}</div>						"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<br/><img src=""tmpXBatir.png"">"		#AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologybeta #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932817866	<div>Which classes of steroid hormones (2) are decreased in <b>17α-hydroxylase deficiency</b>?</div><div><br /></div><div><div><div>{{c1::glucocorticoids and androgens}}</div></div></div>	<i>causes shunting of the steroid synthesis pathway leading to <b>increased mineralocorticosteroid production</b></i>					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""paste-127023657780280.jpg""><br><img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologyalpha #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932795961	<div>What <u>clinical features</u> are seen in <b>17</b><b>α-hydroxylase</b> deficiency that are a result of <u>decreased</u><b> androgen </b>levels in <b>females</b>? </div><div><br /></div><div>{{c1::Lack of sexual development; e.g. lack pubic and axillary hair}}</div>	<i>other symptoms include those of <b>glucocorticoid</b> <b>deficiency</b> and <b>mineralocorticoid excess</b></i><div><i><b><br></b></i></div><div><i><b>androgens</b> are responsible for female pubic and axillary hair</i></div>					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""paste-127526168953912.jpg""><img src=""paste-127191161504824.jpg""><img src=""paste-127019362812984.jpg""><br><img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologyalpha #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932781419	<div>What is the level of <b>aldosterone</b> in <b>17α-hydroxylase deficiency</b>? </div><div><br /></div><div>{{c1::Decreased!}}</div>	<i>Increased levels of 11-deoxycorticosterone (DOC) and corticosterone cause <b>mineralocorticoid</b> <b>excess</b>, leading to <b>renin</b> <b>inhibition</b> (from hypertension), thus leading to decreased angiotensin II and aldosterone</i>					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologyalpha #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932768479	<div>Which <b>adrenal cortex deficiency</b> results in shunting towards the <b>aldosterone synthesis pathway</b>?</div><div><br /></div><div>{{c1::17α-hydroxylase deficiency}}</div>						"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologyalpha #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37932759795	<div>Which <b>adrenal cortex deficiency</b> results in shunting towards the <b>androgen synthesis pathway</b>?</div><div><br /></div><div>{{c1::21β-hydroxylase deficiency}}</div>	"<img src=""paste-496721557717585.jpg"" />"					"<img src=""tmp4WoJeC.png"" /><br /><br/><img src=""tmplR4nMJ.png"" /><br /><br/>"	"<img src=""tmpXBatir.png"">"		#AK_Step1::#B&B::Endocrinology::02_Adrenals::02_Congenital_Adrenal_Hyperplasia #AK_Step1::#FirstAid::endo::phys::adrenal::pathophysiologyalpha #AK_Step1::#Physeo::Endocrinology::Physiology::S08_Congenital_Adrenal_Hyperplasias #AK_Step1::Endocrine::Costanzo::08_Adrenal_Medulla_&_Cortex #AK_Step1::Endocrine::Physiology
-37879203435	The <b>endocrine</b> cells of the pancreas are arranged in clusters called the <b>{{c1::islets of Langerhans}}</b>, which compose 1% to 2% of the pancreatic mass						"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878555646	<div>The <b>{{c2::alpha}}</b> <b>cells</b> of the <b>islets of Langerhans</b> compose 20% of the islet and secrete <b>{{c1::glucagon}}</b> </div>	"<img src=""paste-546014897373525.jpg"" />"					"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878540571	<div>The <b>{{c2::beta}}</b> <b>cells</b> of the <b>islets of Langerhans</b> compose 65% of the islet and secrete <b>{{c1::insulin}}</b> </div>	"<img src=""paste-546010602406229.jpg"" />"					"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878532114	<div>The <b>{{c2::delta}}</b> <b>cells</b> of the <b>islets of Langerhans</b> compose 10% of the islet and secrete <b>{{c1::somatostatin}}</b> </div>	"somatostatin <u>inhibits</u> alpha and beta cells<div><img src=""paste-546010602406229.jpg"" /></div>"					"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878523212	<div>The <b>remaining cells</b> (non-alpha, beta, delta) of the <b>islets of Langerhans</b> secrete {{c1::<b>pancreatic</b> <b>polypeptide</b>}} or other peptides</div>						"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878514412	<div><b>{{c1::Gap junctions}}</b> in the <b>islets of Langerhan</b> link β-cells to each other, α-cells to each other, and β-cells to α-cells, allowing for <b>rapid communication</b> </div>						"<img src=""tmptIaqIo.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878498842	<div>The portal blood supply of the <b>islets of Langerhans</b> allow blood from the <b>{{c1::beta}} cells</b> to bathe the <b>{{c1::alpha}}</b> and <b>{{c1::delta}} cells</b>, further promoting <b>rapid communication</b> </div>	"<div><i>thus, <b>venous</b> <b>blood</b> from the beta cells carries <b>insulin</b> to the alpha and delta cells</i></div><div><i><img src=""paste-546010602406229.jpg"" /></i></div>"					"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878473085	<div>The<b> {{c2::central core}}</b> of the <b>islet of Langerhans</b> contains mostly <b>{{c1::beta}} cells</b> </div>	"<i>insulin secreting</i><div><img src=""paste-546010602406229.jpg"" /></div>"					"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878447992	<div>The <b>{{c2::outer rim}}</b> of the <u>islet of Langerhans</u> contains mostly <b>{{c1::alpha}} cells</b></div>	"<div><i>glucagon secreting</i></div><div><i><img src=""paste-546010602406229.jpg"" /></i></div>"					"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878434860	<div>What is location of the<b> delta cells</b> in the <b>islet of Langerhans</b>?</div><div><br /></div><div>{{c1::Interspersed between alpha and beta cells}}</div>	"<div><i>somatostatin secreting</i></div><div><i><img src=""paste-546010602406229.jpg"" /></i></div>"					"<img src=""tmptIaqIo.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpd7Pr3u.png""><br/>"	#AK_Step1::#FirstAid::endo::phys::pancreas::anatomy #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37878426253	<b>Insulin</b> is a peptide hormone consisting of two straight chains, an <b>{{c1::A}} chain</b> (21 AA) and a <b>{{c1::B}} chain</b> (30 AA), connected by <u>two</u> <b>{{c2::disulfide bridges}}</b> <div><br /></div>	"<div><i>a third disulfide bridge is located within the A chain</i></div><div><i><img src=""paste-547011329786395.jpg"" /></i></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877435430	<div>The synthesis of <b>insulin</b> is directed by a gene on <b>chromosome {{c1::11}}</b> </div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877427592	<div>mRNA directs ribosomal synthesis of <b>{{c1::preproinsulin}}</b>, which contains a <b>signal</b> <b>peptide</b>, the<b> </b>A and B chains of <b>insulin</b>, and a <b>connecting</b> <b>peptide</b> (insulin synthesis) </div>	"<i>occurs in the <b>rough endoplasmic reticulum</b></i><div><i><b><img src=""proinsulin.png"" /></b></i></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877391382	<div>The <b>{{c1::signal peptide}}</b> of <b>preproinsulin</b> is cleaved while the peptide chains are being assembled, yielding <b>{{c2::proinsulin}}</b></div>	"<img src=""proinsulin.png"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877359152	<div><b>Proinsulin</b> is packaged in <b>secretory</b> <b>granules</b> in the {{c1::Golgi apparatus}}</div>						"<img src=""tmpz1Od0y.png"">"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877347229	<div>While being packed into <u>secretory granules</u>, <i>proteases</i> cleave the <b>{{c1::connecting peptide}}</b> of <b>proinsulin</b>, yielding <b>{{c1::insulin}}</b> </div>	"<img src=""proinsulin.png"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877329208	<div><b>Insulin</b> is packaged in secretory granules of the Golgi apparatus with <b>{{c1::C peptide}}</b></div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877318980	<div>When the <b>beta cell</b> is stimulated, exocytosis of <b>insulin</b> and <b>C peptide</b> are released in <b>{{c1::equimolar}} quantities</b> </div>	<i>this is useful for testing beta-cell function in a patient taking exogenous insulin; C-peptide is excreted unchanged in the urine </i>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877298751	<div>What peptide is packaged <i>with insulin</i> and may be used to monitor <b>beta cell function</b> in patients receiving <b>exogenous insulin</b>?</div><div><br /></div><div>{{c1::C peptide (connecting peptide)}}</div>	<i>via urine levels</i>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877290977	What may cause <b>increased</b> levels of <i>both </i><b>insulin</b> and <b>C-peptide</b> (2)? <div><br /></div><div>{{c1::Insulinoma, sulfonylurea drugs}} </div>	<i><br /></i>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37877140832	<div>What may cause <b>increased insulin</b> levels and <b>normal</b> or<b> decreased C-peptide</b> levels?</div><div><br></div><div>{{c1::Exogenous insulin use}}</div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::synthesis #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37876760345	<div><b>{{c1::Glucose}}</b> is the major regulator of <b>insulin release</b></div>	"The rate of insulin release is <u>proportional</u> to glucose levels up to ~300mg/dL<div><img src=""paste-550528908001624.jpg"" /></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::01_Glucose #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872254540	<div>Transport of <b>glucose</b> from blood into the <u>pancreatic β-cell</u> occurs via a <b>{{c1::GLUT2}}</b> transporter</div>	"<div><i>facilitated diffusion.  *This is <b>low affinity, high capacity</b></i></div><div><i><img src=""paste-41669772706243.jpg"" /></i></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::01_Glucose #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872240496	"<div>Once inside the <u>pancreatic β-cell</u>, <b>glucose</b> is <b>{{c1::phosphorylated}}</b> by the enzyme <b style=""font-style: italic; "">{{c2::glucokinase}}</b> </div>"	"<div><i>producing glucose-6-phosphate</i></div><div><i><img src=""paste-41669772706243.jpg"" /></i></div>"					"<img src=""tmpz1Od0y.png""><br/>"	"<br/><img src=""Hexokinase vs Glucokinase - OG copy.png""><img src=""Hexokinase vs Glucokinase - OG.png""><br>"		#AK_Step1::#B&B::Biochemistry::02_Metabolism::02_Glycolysis #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::#Pixorize::Biochem::Misc::Hexokinase_vs_Glucokinase #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872218752	<div>In the <u>pancreatic beta cell</u>, <b>metabolism of glucose </b>generates <b>{{c1::ATP}}</b>, which may cause <u>closure</u> of <i>select</i> <b>K<sup>+</sup> channels</b> with consequent membrane depolarization </div>	"<img src=""paste-41669772706243.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872194087	<div><b>Increased ATP:ADP ratio</b> in the <b>pancreatic</b> <b>beta cell</b> (as a result of glucose metabolism) causes <i>ATP-sensitive</i> <b>{{c1::K<sup>+</sup>}} channels</b> to <b>{{c2::close}}</b>, causing membrane <b>{{c2::depolarization}}</b></div>	"Also allows increased Ca<sup>2+</sup> influx<div><img src=""paste-41669772706243.jpg""><div><br></div><div>- Certain patients with neonatal diabetes mellitus have mutations in this channel in which elevated glucose levels do not lead to appropriate depolarization and insulin release (treat these patients with sulfonylureas)</div><div><br></div><div>- conversely, mutations causing increased affinity for ATP and inappropriate closure of K<sub>ATP</sub> channels would lead to excessive insulin release and frequent hypoglycemia</div></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37872153989	<div><b>Depolarization</b> of the pancreatic <b>beta cell</b> causes <i>voltage-sensitive</i> <b>{{c1::Ca<sup>2+</sup>}} channels</b> to <b>{{c2::open}}</b>, causing an {{c2::increase}} in intracellular {{c1::Ca<sup>2+</sup>}}</div>	"<img src=""paste-41669772706243.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872130376	<div>Increased <b>intracellular Ca<sup>2+</sup></b> in the <u>pancreatic β-cell</u> causes <b>{{c1::exocytosis}} </b>of <b>insulin</b>-containing granules</div>	"<div><i>granules also contain C peptide, which is excreted in the urine</i></div><div><img src=""paste-41669772706243.jpg"" /><i> </i></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872096982	<div>What <i>class</i> of drugs acts by <b>closing K<sup>+</sup> channels</b> in <u>pancreatic beta cells</u>, causing <b>increased insulin secretion</b>? </div><div><br /></div><div>{{c1::sulfonylurea drugs (e.g. tolbutamide, glyburide)}}</div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872070309	<div>Why is <b>oral glucose</b> a <i>more</i> <i>powerful</i> stimulant of <b>insulin secretion</b> than <b>IV glucose</b>? </div><div><br></div><div>{{c1::Oral glucose stimulates secretion of GIP and GLP-1}}</div>	"<img src=""paste-550528908001624.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Gastroenterology::02_Physiology::04_Gastrointestinal_Hormones #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::#Physeo::Gastroenterology::Physiology::S5_Hormones #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872032472	<div>How do <b>sulfonylurea drugs</b> (e.g. tolbutamide, glyburde) cause an <b>increased</b> <b>insulin secretion</b>?</div><div><br /></div><div>{{c1::By closing the ATP-dependent K<sup>+</sup> channels, causing depolarization and subsequent insulin release}}</div><div></div>	"<img src=""paste-41669772706243.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::$AnKingUpdates::#Zanki::NotDoing #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37872014932	<div>What effect does <b>glucagon</b> have on <b>insulin secretion</b>? </div><div><br /></div><div>{{c1::Increased}}</div>	"<div><i><img src=""paste-550528908001624.jpg"" /></i></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871982399	<div>What effect does <b>somatostatin</b> have on <b>insulin secretion</b>? </div><div><br /></div><div>{{c1::Decreased}}</div>	"<div><i>inhibition of the pathway that glucagon stimulates</i> </div><div><img src=""paste-550533202968920.jpg"" /></div>"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Gastroenterology::02_Physiology::04_Gastrointestinal_Hormones #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::regulation #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871971177	<div>The <b>insulin receptor</b> is a tetramer consisting of <u>two</u> <b>{{c1::α}} subunits</b> and <u>two</u> <b>{{c1::β}} subunits</b> </div>	"<img src=""paste-553848917721342.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871963128	<div>The <b>{{c1::alpha}} subunits</b> of the <b>insulin receptor</b> are connected by a disulfide bond and lie in the <b>extracellular domain</b> </div>	"<img src=""paste-553853212688638.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871910818	<div>The <b>{{c1::beta}} subunits</b> of the <b>insulin receptor</b> are connected to the alpha subunit by a disulfide bond and <b>span the cell membrane </b></div>	"<img src=""paste-553848917721342.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871891676	<div>The <b>beta subunits</b> of the <b>insulin receptor</b> have <b>{{c1::<i>intrinsic</i> tyrosine kinase}} activity</b></div>	"<img src=""paste-553848917721342.jpg"" />"					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871879073	<div>When <b>insulin</b> binds to its receptor, {{c1::<b>tyrosine</b> <b>kinase</b>}} is activated and <b>autophosphorylates</b> the <b>β</b>-<b>subunits</b> </div>	<i>the phosphorylated receptor then phosphorylates intracellular proteins</i>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871865280	<div>After phosphorylating intracellular proteins, the<b> insulin receptor</b> is {{c1::<b>internalized</b> (via endocytosis)}} and either degraded, stored, or recycled </div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871846008	<div>What effect does <b>insulin </b>have on <b>insulin receptors</b> in target tissues?</div><div><br /></div><div>{{c1::Causes down-regulation}}</div>	<i>therefore increased insulin (e.g. obesity) may cause insulin resistance</i> 					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871831240	<div>The number of <b>insulin</b> <b>receptors</b> is {{c1::increased}} in <b>starvation</b> and {{c1::decreased}} in <b>obesity</b> </div>	Thus measurement of <b>waist circumference / waist-to-hip</b> ratio is an effective indirect assessment of visceral fat to predict <b>insulin resistance</b>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::mechanismofaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37871821019	<div>What are the <u>three</u> locations that <b>insulin</b> acts on? </div><div><br /></div><div>{{c1::Liver, muscle, and adipose tissue}}</div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871813955	<div>Insulin <b>increases glucose transport</b> to <b>{{c1::muscle}}</b> and <b>{{c1::adipose}} tissue</b> by directing the insertion of the <b>{{c2::GLUT4}}</b> transporter into the cell membranes</div>	<i>exercise can also increase GLUT-4 expression (muscle tissue only); end result is decreased blood glucose concentration</i> 					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::01_Glucose #AK_Step1::#B&B::Biochemistry::02_Metabolism::03_Gluconeogenesis #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871794986	<div><b>Insulin</b> decreases <u>blood glucose concentration</u> by promoting synthesis and storage of <b>{{c1::glycogen}}</b> in the <b>{{c2::muscle}}</b> and <b>{{c2::liver}}</b>, while simultaneously inhibiting <b>{{c1::glycogenolysis}}</b> </div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::01_Glucose #AK_Step1::#B&B::Biochemistry::02_Metabolism::03_Gluconeogenesis #AK_Step1::#B&B::Biochemistry::02_Metabolism::04_Glycogen #AK_Step1::#B&B::Biochemistry::02_Metabolism::13_Exercise_Starvation #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871768580	<div><b>Insulin</b> decreases <u>blood glucose concentration</u> by decreasing <b>{{c1::gluconeogenesis}}</b> via increased production of <i>fructose-2,6-bisphosphate</i></div>	Thus in insulin resistance, there is increased hepatic glucose production					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::02_Glycolysis #AK_Step1::#B&B::Biochemistry::02_Metabolism::03_Gluconeogenesis #AK_Step1::#B&B::Biochemistry::02_Metabolism::13_Exercise_Starvation #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37871756547	<div>In <b>adipose</b> tissue, <b>insulin</b> <i>stimulates</i> {{c1::fat deposition (increased triglyceride synthesis)}} and <i>inhibits</i> {{c1::lipolysis}} </div>	Thus in insulin resistance, patients have <b>high TAG</b> and <b>low</b> <b>HDL </b>levels					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37871735911	<div><b>Insulin</b> inhibits <b>{{c1::ketoacid}}</b> <b>formation</b> in the <b>liver</b> because decreased fatty acid degradation provides less acetyl CoA substrate for ketoacid formation</div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871722647	<div><b>Insulin</b> stimulates<b> amino acid uptake </b>into cells and {{c1::increases}} <b>protein</b> <b>synthesis</b> in muscles</div>	<i>insulin also decreases protein degradation,</i> <i>thus, insulin is <b>anabolic</b> </i>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::13_Exercise_Starvation #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871652763	<div><b>Insulin</b> results in {{c1::increased}} <b>K<sup>+ </sup>uptake</b> into cells</div>	<i>by increasing the activity of the Na<sup>+</sup>-K<sup>+</sup>-ATPase pump</i>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::$AnKingUpdates::#Zanki::NotDoing #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871632765	<div>What is the effect of <b>insulin</b> on <b><i>blood</i></b> <b>K<sup>+</sup> </b>and<b> amino acid concentration</b>?</div><div><br /></div><div>{{c1::Decreased (due to increased uptake into cells)}}</div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871615531	<div>What is the effect of <b>insulin</b> on <b>Na<sup>+</sup> retention</b> in the kidneys?</div><div><br /></div><div>{{c1::Increased retention}}</div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#B&B::Renal::03_Electrolytes::02_Sodium_Water_Balance #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871601136	<div>Does <b>glucose</b> cross the placenta? What about <b>insulin</b>? </div><div><br /></div><div>{{c1::Glucose does; insulin does not}}</div>						"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Reproductive::02_Pregnancy::02_Placenta #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::targettissueaction #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871594862	<div>What are the <i>blood</i> concentration levels of <b>amino acids</b> and <b>fatty acids</b> in a <b>diabetes mellitus</b> patient? </div><div><br /></div><div>{{c1::Increased}}</div>	<i>due to increased protein catabolism and lipolysis resulting from decreased insulin</i>					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::insulin::pathophysiology #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871550914	<div>What is the cause of <b>metabolic acidosis</b> in a patient with <b>diabetes mellitus</b>?</div><div><br /></div><div>{{c1::Increased production of ketoacids}}</div>	<i>may cause increased ventilation rate to compensate</i> 					"<img src=""tmpz1Od0y.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::11_Ketone_Bodies #AK_Step1::#B&B::Endocrinology::03_Pancreas::02_Diabetes #AK_Step1::#B&B::Renal::02_Acid_Base::06_Metabolic_Acidosis #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::pathophysiology #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37871540102	<div>What is the <i>blood</i> concentration of <b>K<sup>+</sup></b> in a patient with<b> diabetes mellitus</b>?</div><div><br /></div><div>{{c1::Increased (<b>hyperkalemia</b>) due to decreased K<sup>+</sup> uptake into cells}}</div>						"<img src=""tmpz1Od0y.png""><br/>"	"<br/><img src=""tmpEA81g7.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::pancreas::insulin::pathophysiology #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37869566468	<b>{{c1::Glucagon}}</b>, an <b>endocrine</b> <b>hormone</b>, is a member of a family of peptides that includes the GI hormones <b>secretin </b>and <b>GIP</b> 						"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868298122	<div><b>Glucagon</b> acts on the <b>{{c1::liver}}</b> (primarily) and <b>{{c1::adipose}}</b> tissue</div>	Liver: to promote gluconeogenesis, glycogen breakdown and decrease in glycolysis<div>Adipose: increased activity of adipose triglyceride lipase (leads to more non-esterified fatty acids in the blood) and reduced malonyl CoA</div>					"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::02_Glycolysis #AK_Step1::#B&B::Biochemistry::02_Metabolism::13_Exercise_Starvation #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S06_Diabetes #AK_Step1::#Physeo::Gastroenterology::Physiology::S3_Liver_and_Bilirubin_Metabolism #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868273885	<div>The major factor that stimulates <b>glucagon secretion </b>is {{c1::hypoglycemia}}</div>						"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::02_Glycolysis #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S06_Diabetes #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868216847	<div>What is the effect of <b>insulin</b> on <b>glucagon secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>	"<div><i>also decreased by hyperglycemia and somatostatin</i></div><div><i><img src=""paste-557559769465060.jpg"" /></i></div>"					"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::02_Glycolysis #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868200963	<div><div>Through which <u>secondary messenger(s)</u> does <b>glucagon</b> exert its actions on liver and adipose tissue?</div><div><br /></div><div>{{c1::cAMP}}</div></div><div><br /></div><div><b><br /></b></div>						"<img src=""paste-e2094f6424beb4a748ecbd59273e780c682eebbe.jpg""><div><img src=""tmp5WGkQ1.png""><br></div>"			#AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868197724	<div><b>Glucagon</b> <i>increases</i> <u>blood glucose concentration</u> by increasing <b>{{c1::glycogenolysis}}</b>, while simultaneously inhibiting <b>{{c1::glycogen}}</b> formation from glucose</div>						"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::03_Gluconeogenesis #AK_Step1::#B&B::Biochemistry::02_Metabolism::04_Glycogen #AK_Step1::#B&B::Biochemistry::02_Metabolism::13_Exercise_Starvation #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S06_Diabetes #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868176125	<div><b>Glucagon</b> <i>increases</i> <u>blood glucose concentration</u> by increasing <b>{{c1::gluconeogenesis}}</b> via decreased production of <i>fructose-2,6-bisphosphate</i> </div>						"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::02_Glycolysis #AK_Step1::#B&B::Biochemistry::02_Metabolism::03_Gluconeogenesis #AK_Step1::#B&B::Biochemistry::02_Metabolism::13_Exercise_Starvation #AK_Step1::#B&B::Endocrinology::03_Pancreas::01_Endocrine_Pancreas #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S06_Diabetes #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868168494	<div><b>Glucagon</b> causes {{c1::decreased}} <b>fatty</b> <b>acid</b> <b>synthesis</b> and {{c1::increased}} <b>lipolysis</b>, which shunts substrates towards gluconeogenesis</div>						"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#B&B::Biochemistry::02_Metabolism::13_Exercise_Starvation #AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S06_Diabetes #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868150179	<div>What is the effect of <b>glucagon</b> on <i>blood</i> <b>fatty acid</b> and <b>ketoacid concentration</b>?</div><div><br /></div><div>{{c1::Increased, due to increased lipolysis}}</div>	"<img src=""paste-557598424170649.jpg"" />"					"<img src=""tmp5WGkQ1.png""><br/>"	"<div><img src=""paste-6e61864f261dcf0bddc3c2687ae8a95f9b0e7ec8.jpg""><br></div><div><img src=""paste-5be6502f42007f7f3bf3162f5c5cc8854c5fdd0b.jpg""><br></div><div><img src=""paste-18dfedabf03670274e09e5ef0d55808c3fad42a4.jpg""><br></div>"		#AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S05_Insulin_and_Glucagon #AK_Step1::#Physeo::Endocrinology::Physiology::S06_Diabetes #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868142171	<div>What is the effect of <b>glucagon</b> on <b>urea production</b>?</div><div><br /></div><div>{{c1::Increased, secondary to increased gluconeogenesis}}</div>	<i>amino acids are used for gluconeogenesis, and the resulting amino groups are incorporated into urea</i> 					"<img src=""tmp5WGkQ1.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::glucagon #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868130029	<div>Which nutrients (glucose, amino acids, fatty acids) stimulate release of <b>somatostatins</b>?</div><div><br /></div><div>{{c1::All three :)}}</div>						"<img src=""tmpJwWavw.png"">"			#AK_Step1::#Physeo::Gastroenterology::Physiology::S5_Hormones #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868125544	<div>What is the effect of <b>insulin</b> on <b>somatostatin secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>						"<img src=""tmpJwWavw.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::pancreas::somatostatin #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868121576	<div>What is the effect of <b>somatostatin</b> on <b>insulin</b> and <b>glucagon secretion</b>?</div><div><br /></div><div>{{c1::Decreased}}</div>	<i>also inhibits gastrin secretion</i> 					"<img src=""tmpJwWavw.png""><br/>"			#AK_Step1::#B&B::Gastroenterology::02_Physiology::04_Gastrointestinal_Hormones #AK_Step1::#FirstAid::endo::phys::pancreas::somatostatin #AK_Step1::#Physeo::Gastroenterology::Physiology::S5_Hormones #AK_Step1::Endocrine::Costanzo::09_Endocrine_Pancreas #AK_Step1::Endocrine::Physiology
-37868114268	What percent of total <b>Ca<sup>2+</sup> </b>in the blood is <b>bound to plasma protein</b>?<div><br /></div><div>{{c1::40%}} </div>	"<img src=""paste-559204741939458.jpg"" />"					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866386102	<div>What percent of total <b>Ca<sup>2+</sup> </b>in the blood is <b>ultrafilterable</b>?</div><div><br /></div><div>{{c1::60%}}</div>	"<img src=""paste-559200446972162.jpg"" />"					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866368833	<div>What percent of total <b>Ca<sup>2+</sup> </b>in the blood exists in an <b>ionized form</b> (i.e. as Ca<sup>2+</sup>)?</div><div><br /></div><div>{{c1::45-50%}}</div>	"<div><i>this is the only form of Ca<sup>2+</sup> that is biologically active</i> </div><div><img src=""paste-559200446972162.jpg"" /></div>"					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866350271	<div>What percent of total <b>Ca<sup>2+</sup> </b>in the blood is <b>complexed to anions</b> (e.g. sulfate, citrate, phosphate)?</div><div><br /></div><div>{{c1::10-15%}}</div>	"<img src=""paste-559200446972162.jpg"" />"					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866342460	"<div>What is the <i>only</i> form of <b>biologically active Ca</b><sup style=""font-weight: bold; "">2+</sup>? </div><div><br /></div><div>{{c1::Free, ionized Ca<sup>2+</sup>}}</div>"						"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866336827	<div>Hyperreflexia, spontaneous twitching, muscle cramping, tingling, and numbness are signs of which <b>calcium imbalance</b>? </div><div><br /></div><div>{{c1::Hypocalcemia}} </div>						"<img src=""tmpTcNVkO.png""><br/>"	"<div><img src=""paste-615756576326680.jpg"" /></div><img src=""paste-615662087046168.jpg"" /><div><br /></div>"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology #AK_Step2::Dorian::surg::uw
-37866329297	<div>The <b>{{c3::Chvostek}} sign</b> is {{c2::twitching of the facial muscles}} elicited by tapping on the facial nerve; it is an indicator of <b>{{c1::hypocalcemia}}</b> </div>						"<img src=""tmpTcNVkO.png""><br/>"	"<img src=""paste-615842475672600.jpg"" />"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866306095	<div>The <b>{{c3::Trousseau}} sign</b> is {{c1::carpopedal spasm}} upon inflation of a blood pressure cuff; it is an indicator of <b>{{c2::hypocalcemia}}</b> </div>						"<img src=""tmpTcNVkO.png""><br><div><img src=""paste-f0f09c4cfc138911ce4b338f1e3032692f05a8e1.jpg""><br></div><div><img src=""paste-21a0b28d9b52a90ab5e9c2e42ec4c1e95b718cde.jpg""><br></div>"	"<img src=""paste-615928375018520.jpg"" /><br/><img src=""Vitamin D (Calciferol) Deficiency & Excess - OG copy.jpg""><img src=""Vitamin D (Calciferol) Deficiency & Excess - OG.jpg""><br/>"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::#Pixorize::Biochem::Vitamins::D_Deficiency_&_Excess #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866295712	<div>Why does <b>hypocalcemia</b> cause symptoms such as <b>tingling</b>/<b>numbness</b> and <b>twitching</b>/<b>cramping</b>?</div><div><br></div><div>{{c1::Decreased <u>extracellular</u> Ca<sup>2+</sup> decreases the <u>threshold potential</u> (makes it less negative)}}</div>	<i>thus, it is easier for cells to depolarize to threshold and more action potentials are fired</i><div><i><br></i></div><div><i>early sign of <b>hypoparathyroidism</b>-especially perioral</i></div>					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::$AnKingUpdates::$Errata::v6 #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866281732	<div>Constipation, polyuria, polydipsia, lethargy, and hyporeflexia are signs of which <b>calcium imbalance</b>? </div><div><br /></div><div>{{c1::Hypercalcemia}} </div>						"<img src=""tmpTcNVkO.png""><br><div><img src=""paste-252230544392552.jpg""><br></div>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866253223	<div>What is the effect of <b>acidemia</b> on free ionized Ca<sup>2+</sup> concentration?</div><div><br /></div><div>{{c1::Increased}}</div>	"<div><i>more H<sup>+</sup> binds to albumin, leaving fewer sites for Ca<sup>2+</sup> to bind --&gt; hypercalcemia</i></div><div><img src=""paste-559436670173436.jpg"" /></div>"					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::calciumforms #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866242668	<div><div>What is the effect of <b>alkalemia</b> on free ionized Ca<sup>2+</sup> concentration?</div><div><br /></div><div>{{c1::Decreased}}</div></div>	"<div><i>less H<sup>+</sup> binds to albumin, leaving more sites for Ca<sup>2+</sup> to bind</i> --&gt; hypocalcemia</div><div><img src=""paste-559436670173436.jpg"" /></div>"					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::calciumforms #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866229011	<div><div>Which <u>three</u> organ systems are involved in <b>Ca<sup>2+</sup> homeostasis</b>? </div></div><div><br /></div><div>{{c1::Bone, kidney, and intestine}}</div>	"<div><i>to maintain balance of Ca<sup>2+</sup>, net intestinal absorption must be balanced by urinary excretion</i></div><div><i><img src=""paste-559466734944744.jpg"" /></i></div>"					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::calciumhomeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866210197	<div>Which <u>three</u> hormones are involved in <b>Ca<sup>2+</sup> homeostasis</b>?</div><div><br /></div><div>{{c1::Parathyroid hormone, calcitonin, and vitamin D (1,25-dihydroxycholecalciferol)}}</div>	"<img src=""paste-559462439977448.jpg"" />"					"<img src=""tmpTcNVkO.png""><br><div><img src=""paste-70ccf36dd513e91fd3a6a84295a25a438d5ddf0d.jpg""><br></div>"	"<br/><img src=""Vitamin D (Calciferol) Biochemistry - OG copy.jpg""><img src=""Vitamin D (Calciferol) Biochemistry - OG.jpg""><br/>"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::calciumhomeostasis #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Biochemistry #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866202234	<div>What demographic is associated with <b>positive Ca<sup>2+</sup> balance</b>?</div><div><br /></div><div>{{c1::Growing children}}</div>	<i>intestinal Ca<sup>2+</sup> absorption exceeds urinary excretion; excess is deposited in growing bones</i> 					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::calciumhomeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37866194477	<div>What demographic is associated with <b>negative Ca<sup>2+</sup> balance</b>?</div><div><br /></div><div>{{c1::Women during pregnancy or lactation}}</div>	<i>intestinal Ca<sup>2+</sup> absorption is less than urinary excretion; the deficit comes from the maternal bones</i> 					"<img src=""tmpTcNVkO.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::calciumhomeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37864557263	<div><b>Parathyroid hormone</b> is synthesized and secreted by the <b>{{c1::chief}} cells</b> of the parathyroid glands </div>	<b>calcitonin</b> is secreted by the <b>parafollicular (C) cells</b>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-441522638029848.jpg"" />"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::synthesis #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862821061	<div><b>Parathyroid hormone (PTH)</b> secretion is regulated by plasma {{c1::Ca<sup>2+</sup>}} concentration</div>	"<img src=""paste-560725160362238.jpg"" />"					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862811241	<div><div>When plasma <b>Ca<sup>2+</sup></b> concentrations <b>{{c1::decrease}}</b>,</div><div> <b>parathyroid hormone </b>secretion is <b>{{c2::increased}}</b> (and vice versa)</div></div>	"<div><i>it is the <u>ionized</u> Ca<sup>2+</sup> concentration that regulates secretion</i></div><div><i><img src=""paste-560729455329534.jpg"" /></i></div>"					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862794837	<div>Secretion of <b>PTH</b> is controlled by <u>extracellular</u> (serum) Ca<sup>2+</sup> binding to <b>{{c1::Ca<sup>2+</sup>-sensing}} receptors</b> in the parathyroid cell membrane</div>	<i>decreased binding of Ca<sup>2+</sup> to its receptor results in increased PTH secretion</i>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862737268	<div><i>Chronic</i> <b>hypocalcemia</b> causes <b>secondary </b>{{c1::hyperparathyroidism}}, which is characterized by increased synthesis and storage of PTH and hyperplasia of the parathyroid glands</div>						"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-e7db8b249732629ac2ae3e34b35477c5d0880e70.jpg"">"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862717728	<div>{{c2::<i>Mild</i> <b>decreases</b>}} in serum <b>Mg<sup>2+</sup> </b>concentration cause {{c1::<u>increased</u>}} <b>PTH</b> secretion</div>	<i>similar to calcium</i>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862694628	<div>{{c2::<i>Severe</i> <b>decreases</b>}} in serum <b>Mg<sup>2+</sup> </b>concentration cause {{c1::<u>decreased</u>}} <b>PTH</b> secretion</div>	<div><i>common causes of Mg<sup>2+</sup> depletion include <b>diarrhea</b>, aminoglycosides, diuretics, and <b>alcohol</b> <b>abuse</b>;</i></div><div><i>mimics symptoms of hypoparathyroidism, e.g. <b>hypocalcemia</b></i></div>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862683583	"<div>What is the effect of <u>increased</u><b> </b>serum <b>PO</b><sub style=""font-weight: bold; "">4</sub><sup style=""font-weight: bold; "">3-</sup><b> </b>on <b>PTH secretion</b>?</div><div><br /></div><div>{{c1::Increased}}</div>"	<i>conversely, increased PTH secretion causes decreased serum PO<sub>4</sub><sup>3-</sup> and increased urine PO<sub>4</sub><sup>3-</sup> </i>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862654054	<div>The actions of <b>PTH</b> are coordinated to produce an <b>increase</b> in serum {{c1::Ca<sup>2+</sup>}} and a <b>decrease</b> in serum {{c1::phosphate (PO<sub>4</sub><sup>3-</sup>)}}</div>	"<div><i>image shows decreased phosphate reabsorption in the kidney</i></div><div><img src=""paste-562941363487070.jpg"" /></div>"					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::regulation #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862566204	<div>Through what <u>secondary messenger(s)</u> does <b>PTH</b> exert its actions on bone and kidney tissue?</div><div><br /></div><div>{{c1::cAMP}}</div>	"<img src=""paste-562945658454366.jpg"" />"					"<img src=""paste-e2094f6424beb4a748ecbd59273e780c682eebbe.jpg""><div><img src=""tmpoLu3dM.png""><br><img src=""tmpasZGFo.png""><br></div>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::04_Signalling_Pathways #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862558572	<div>In <i>bone</i>, <b>PTH receptors</b> are located on <b>{{c1::osteoblasts}}</b>, but <u>not</u> on <b>{{c1::osteoclasts}}</b> </div>						"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862547930	<div><i>Initially</i> and <i>transiently</i>, <b>PTH</b> causes an increase in <b>bone {{c1::formation}}</b> by a direct action on {{c1::osteoblasts}}</div>	"<i>this brief action is the basis for intermittent synthetic PTH administration in the treatment of </i><b style=""font-style: italic; "">osteoporosis</b> "					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<div><img src=""paste-ad51cc0925e09996be7a080dc4d68185c6816535.jpg""><br></div>"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862534805	<div>In <i>bone</i>, the <i>long-term</i> effect of <b>PTH</b> is <b>bone {{c1::resorption}}</b> via <u>indirect</u> action on {{c1::osteoclasts}}</div>						"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862520855	<div>The action of <b>PTH</b> on <b>osteoclasts</b> is <u>indirect</u> and mediated by <b>cytokines</b> released from <b>{{c1::osteoblasts}}</b> </div>	<div><i>the cytokines increase the number and activity of osteoclasts</i></div><div><i><br /></i></div>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862504810	<div><b>Resorption</b> of the organic matrix of bone is reflected in <b>increased {{c1::hydroxyproline}} excretion</b> in the urine </div>						"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862491535	<div>The <i>overall</i> effect of <b>PTH</b> on <i>bone</i> is to promote <b>bone</b> <b>{{c1::resorption}}</b>, which delivers <i>both</i> {{c2::<b>Ca</b><sup><b>2+</b></sup>}} and <b>{{c2::phosphate}}</b> to extracellular fluid</div>						"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862475182	<div>Will the effect of <b>PTH</b> on bone <i>alone </i>increase <b>ionized Ca<sup>2+</sup></b> concentration?</div><div><br /></div><div>{{c1::No, the calcium released would complex with the released phosphate, hence the importance of the <u>phosphaturic action</u> of PTH on the <i>kidney</i>}}</div>						"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862468854	<div><b>PTH </b>acts on the kidney to <u>inhibit</u> renal <b>{{c1::phosphate}} reabsorption</b> in the <b>{{c2::proximal convoluted tubule}}</b>, which therefore increases phosphate excretion (<b>phosphaturic effect</b>) </div>	<i>as a result, the phosphate resorbed from bone is excreted in the urine, allowing the serum ionized Ca<sup>2+</sup> to increase</i> 					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862406699	<div>The <b>cAMP</b> generated as a result of the action of <b>PTH</b> on the <b>proximal</b> <b>tubule</b> is excreted in the {{c1::urine (<b>urinary cAMP</b>)}}</div>						"<img src=""paste-e2094f6424beb4a748ecbd59273e780c682eebbe.jpg""><div><img src=""tmpoLu3dM.png""><br><img src=""tmpasZGFo.png""><br></div>"			#AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862398134	<div><b>PTH </b>acts on the kidney to <u>increase</u> renal <b>{{c1::calcium}} reabsorption</b> in the <b>{{c2::distal convoluted tubule}}</b></div>	<i>complements the increase in plasma Ca<sup>2+</sup> concentration that results from bone resorption</i> 					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862381959	<div><b>PTH</b> stimulates the <b>renal</b> <b>enzyme</b> <b>{{c1::1α-hydroxylase}}</b>, which converts 25-hydroxycholecalciferol to the active form, <b>1,25-dihydroxycholecalciferol</b> (vitamin D)</div>	<i>1,25-dihydroxycholecalciferol stimulates intestinal Ca<sup>2+</sup> absorption</i>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<br/><img src=""Vitamin D (Calciferol) Biochemistry - OG copy.jpg""><img src=""Vitamin D (Calciferol) Biochemistry - OG.jpg""><br/>"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Biochemistry #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862320434	<div>How does <b>PTH</b> increase <i>intestinal</i> <b>Ca<sup>2+&nbsp;</sup></b><b>absorption</b>?</div><div><br></div><div>{{c1::<u>Indirectly</u>, by stimulating production of <b>1,25-(OH)<sub>2</sub>D<sub>3</sub> </b>in the kidney}}</div>	<i>increases production by stimulating 1α-hydroxylase in the proximal tubule</i>					"<img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""Vitamin D (Calciferol) Biochemistry - OG copy.jpg""><img src=""Vitamin D (Calciferol) Biochemistry - OG.jpg"">"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::action #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Biochemistry #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862288285	"<div><u>PTH Actions Summary Picture</u>: no answer {{c1:::)}}</div><div><br /></div><div><img src=""paste-563126047080990.jpg"" /></div>"						"<img src=""tmpoLu3dM.png""><br><img src=""tmpasZGFo.png"">"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::01_Embryo/Anatomy/Phys::06_Renal_Endocrine_Function #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37862285229	<b>Primary hyperparathyroidism</b> is most commonly caused by a {{c1::<b>parathyroid adenoma</b> (which secretes excess PTH)}}						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-441432443716632.jpg"" />"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::MSK::03_Pathology::01_Bone_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::primaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859512243	<div><b>{{c1::Primary hyperparathyroidism}}</b> is characterized by <b>hypercalcemia</b>, <b>hypophosphatemia</b>, and <u>increased</u> circulating levels of <b>PTH</b></div>	<i>hypercalcemia and hypophosphatemia are results of elevated PTH levels</i> 					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-443528387757080.jpg"">"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::primaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859503111	<div>Patients with <b>primary hyperparathyroidism</b> have {{c1::increased}} Ca<sup>2+</sup> excretion due to the high <i>filtered load</i> of calcium on the kidney</div>						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::primaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859486170	<div>What is a possible complication of <b>increased Ca<sup>2+</sup> </b>in the <b>urine</b> (e.g. due to primary hyperparathyroidism)? </div><div><br /></div><div>{{c1::Calcium-oxalate kidney stones}} </div>						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-444911367226392.jpg"" />"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::05_Other::04_Kidney_Stones #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::primaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859477643	<div>Patients with <b>primary</b> <b>hyperparathyroidism</b> have {{c1::increased}} <b>urinary</b> <b>excretion</b> of phosphate, calcium, and cAMP </div>	<i>phosphate and cAMP due to increased PTH; calcium due to high filter pressure</i>					"<img src=""tmplNRCUJ.png""><br><img src=""tmpTG7qfI.png""><br><img src=""tmpoLu3dM.png""><br><img src=""tmpasZGFo.png""><img src=""paste-e2094f6424beb4a748ecbd59273e780c682eebbe.jpg""><br>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::primaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859469693	"<div>Which parathyroid disorder is characterized by ""<b>stones</b>, <b>bones</b>, <b>groans</b>, and <b>psychiatric undertones</b>""? </div><div><br /></div><div>{{c1::Primary hyperparathyroidism}}</div>"	<div><i> - Stones from hypercalciuria </i></div><div><i> - Bones from increased bone resorption</i></div><div><i> - Groans from constipation</i></div><div><i> - Psychiatric undertones from depression </i></div>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"		"<div><i><img src=""paste-4327944054898689.jpg""></i></div><div><br></div>"	#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::primaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology #AK_Step2::Dorian::im::emma
-37859462877	<div>What is the treatment for a patient with <b>primary hyperparathyroidism</b>? </div><div><br /></div><div>{{c1::Parathyroidectomy}}</div>						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::primaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology #AK_Step2::Zanki_Step_2::IM::Endocrine,_Diabetes,_&_Metabolism_
-37859457242	<div>In <b>secondary hyperparathyroidism</b>, PTH levels are elevated <i>secondary</i> to {{c1::hypocalcemia (or hyperphosphatemia)}}</div>						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::secondaryhyperparathyroidism #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859451943	<div><b>Hypoparathyroidism</b> is most commonly a result of <b>{{c1::thyroid surgery}}</b>, or less commonly may be {{c3::<b>autoimmune</b>}} or <b>{{c2::congenital}}</b> </div>	Autoimmune - AIRE mutation (hypoparathyroidism, adrenal insufficiency, Chronic mucocutaneous candidiasis)<br><div>Congenital - ex = digeorge syndrome </div>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<div><img src=""paste-d8996cfbc9f41a4aadbb193268f0c3d5ba5f9327.jpg""><br></div><div><img src=""paste-299dfffa637afdb53d6a7cc661af4c230bd48d19.jpg""><br></div><div><img src=""paste-de712c31edb24d9cdebfc6cabc82b0379cd9fafe.jpg""><br></div>"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::hypoparathyroidism #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37859440599	<div><b>Hypoparathyroidism </b>is characterized by <b>decreased</b> serum {{c1::calcium (hypocalcemia)}} and <b>increased</b> serum {{c1::phosphate (hyperphosphatemia)}} </div>	<i>also have decreased urinary phosphate excretion; treatment involves oral Ca<sup>2+</sup> and vitamin D supplementation</i> 					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"		"<i><img src=""paste-4327944054898689.jpg""></i>"	#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::hypoparathyroidism #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::im::emma
-37859427762	<div><b>Pseudohypoparathyroidism type 1a</b>, or <b>Albright hereditary osteodystrophy</b>, is due to a defective <b>{{c1::G<sub>s</sub>}}</b> protein in the <b>kidney</b> and <b>bone</b>, which causes end-organ resistance to <b>{{c2::PTH}}</b> </div>						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-34029025887310.jpg"" /><img src=""paste-34406983009336.jpg"" />"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::pseudophypoparathyroidism #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859412440	<div>{{c1::Pseudohypoparathyroidism type 1a}} is characterized by <b>hypocalcemia</b> and <b>hyperphosphatemia </b>that is <u>not correctable</u> by administration of <b>exogenous PTH</b> </div>	<i>also known as Albright hereditary osteodystrophy</i>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-34406983009336.jpg"">"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::pseudophypoparathyroidism #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab
-37859406476	<div>What is the difference in <b>PTH</b> levels in <b>hypoparathyroidism</b> versus</div><div> <b>pseudohypoparathyroidism</b>?</div><div><br></div><div>{{c1::PTH levels are <i>elevated</i> in pseudohypoparathyroidism due to stimulation by hypocalcemia}}</div>	<i>decreased in hypoparathyroidism</i>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-34205119546446.jpg""><img src=""paste-34406983009336.jpg"">"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::pseudophypoparathyroidism #AK_Step1::#Pathoma::15_Endocrine::15.08-Parathyroid_Gland #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Pathology
-37859364228	<div>Some {{c1::<b>malignant</b> <b>tumors</b>}} secrete <b>{{c2::PTH-related peptide (PTH-rp)}}</b>, which is structurally <i>homologous</i> with the PTH secreted by the parathyroid glands</div><div><br /></div><div><b><br /></b></div>	i.e. Squamous Cell Lung Carcinoma and Renal Cell Carcinoma					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::malignancy #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859359677	<div><b>{{c1::Humoral hypercalcemia of malignancy}}</b> is due to <b>increased {{c2::PTH-rp}} secretion</b> and presents<i> </i>similarly to<i> hyperparathyroidism</i> (e.g. hypercalcemia, hypophosphatemia)</div>						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-35961761170510.jpg"" />"		#AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::malignancy #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859324034	<div><b>Humoral hypercalcemia of malignancy</b> may be treated with <b>{{c1::zoledronate&nbsp;(a bisphosphonate)}} or&nbsp;{{c1::pamidronate}}</b>, which inhibits bone resorption</div>	"Per UpToDate: ""The inconvenience of prolonged IV treatment and the relatively weak potency of etidronate <i>(which this card previously said)</i> have diminished its utility, and it is not generally recommended unless other bisphosphonates are not available"""					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-d2645218fee420c0bff1d399904a695093b633da.jpg"" draggable=""false""> <div><img src=""paste-faac63aacf57e4a5184c9c81f6739c644689a077.jpg"" draggable=""false""> <br>  <div> <br> </div> </div> "		#AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::malignancy #AK_Step1::$AnKingUpdates::$Errata::v6 #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859319041	<div>{{c2::<b>Familial hypocalciuric hypercalcemia</b> <b>(FHH)</b>}} is caused by <b>inactivating mutations</b> of the <b>{{c1::Ca<sup>2+</sup>-sensing receptors}}</b> that regulate PTH secretion</div>	<i>presents with decreased urinary Ca<sup>2+</sup> excretion and increased serum Ca<sup>2+</sup> (as the name suggests)</i>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-36442797507662.jpg""><img src=""paste-36223754175566.jpg"">"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::fhh #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology #AK_Step2::Zanki_Step_2::IM::Endocrine,_Diabetes,_&_Metabolism_
-37859305113	<div>What is the inheritance of <b>familial hypocalciuric hypercalcemia (FHH)</b>? </div><div><br /></div><div>{{c1::Autosomal dominant}}</div>						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-36228049142862.jpg"" />"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::fhh #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859231317	<div>What is the effect of <b>chronic renal failure</b> on <b>serum phosphate levels</b>?</div><div><br /></div><div>{{c1::Increased}}</div>	<i>decreased glomerular filtration rate (GFR) leads to decreased filtration of phosphate</i>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::renalfailure #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859213232	"<div>In <b>chronic renal failure</b>, increased serum phosphate complexes Ca<sup>2+</sup> and leads to <b>decreased</b> {{c1::free, <b>ionized Ca</b><sup style=""font-weight: bold; "">2+</sup>}} </div>"						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::renalfailure #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859208536	"<div>In <b>chronic renal failure</b>, decreased <i>production</i> of the active form of <b>vitamin</b> <b>{{c1::D, (1,25-dihydroxycholecalciferol)}}</b> by the kidney contributes to <b>decreased ionized Ca</b><sup style=""font-weight: bold; "">2+</sup> </div>"	<i>decreased vitamin D causes decreased Ca<sup>2+</sup> absorption in the intestine</i>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::MSK::03_Pathology::01_Bone_Disorders #AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::renalfailure #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859182620	"<div>The <u>decreased</u><b> ionized Ca</b><sup style=""font-weight: bold; "">2+</sup> in <b>chronic renal failure</b> causes <b>{{c1::secondary hyperparathyroidism}}</b>, which is characterized by increased levels of PTH</div>"						"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"	"<img src=""paste-612415091770392.jpg"" />"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::renalfailure #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37859162259	In <b>{{c2::chronic renal failure}}</b>, the combination of <i>elevated</i> <b>PTH</b> and <i>decreased</i> <b>1,25-(OH)<sub>2</sub>D<sub>3</sub></b> produces <b>{{c1::renal osteodystrophy}}</b>, in which there is <u>increased</u> <b>bone resorption</b> and <b>osteomalacia</b> 	- Due to secondary hyperparathyroidism, patient presents with bone pain, painful nodules / skin necrosis (due to tissue calcifications), electrolyte abnormalities<div><br /></div><div>- if left untreated / develops further, constant stimulation of parathyroid leads to tertiary hyperparathyroidism (Osteitis Fibrosa Cystica - bone pain and fractures due to bone cysts and brown tumors)</div>					"<img src=""tmplNRCUJ.png""><br/><img src=""tmpTG7qfI.png""><br/><img src=""tmpoLu3dM.png""><br/><img src=""tmpasZGFo.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#B&B::MSK::03_Pathology::01_Bone_Disorders #AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::pth::pathophysiology::renalfailure #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37859149506	<b>{{c2::Calcitonin}}</b> is secreted by the {{c1::<b>parafollicular cells</b> (C cells)}} of the <b>thyroid</b> <b>gland</b> 						"<img src=""tmpXwevTI.png""><br/>"			#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#B&B::MSK::03_Pathology::03_Osteoporosis_Drugs #AK_Step1::#FirstAid::endo::phys::parathyroid::calcitonin #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37856099277	<div>The major <i>stimulus</i> for <b>calcitonin secretion</b> is {{c1::hypercalcemia}}</div>	<i>versus PTH, which is released in response to decreased calcium; not important in normal Ca<sup>2+</sup> homeostasis</i> 					"<img src=""tmpXwevTI.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::calcitonin #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37856085133	<div>The major <i>function</i> of <b>calcitonin</b> is to <u>inhibit</u><b> bone {{c1::resorption}}</b>, thus decreasing the plasma Ca<sup>2+</sup> concentration </div>						"<img src=""tmpXwevTI.png""><br/>"			#AK_Step1::#B&B::MSK::03_Pathology::03_Osteoporosis_Drugs #AK_Step1::#FirstAid::endo::phys::parathyroid::calcitonin #AK_Step1::#Physeo::Endocrinology::Physiology::S04_Calcium_homeostasis #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37856073453	<b>Calcitonin</b> may be used to treat which <b>calcium imbalance</b>? <div><b><br /></b></div><div><b>{{c1::hypercalcemia}}</b></div>						"<img src=""tmpXwevTI.png""><br/>"	"<img src=""paste-c58119046aec53a6212e1bd1f9c25369dac3dc99.jpg"">"		#AK_Step1::#FirstAid::endo::phys::parathyroid::calcitonin #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37854156855	<div>One <i>external</i> source of <b>vitamin D</b> (cholecalciferol) in the body is through <b>{{c1::ingestion/diet}}</b></div>	"<img src=""paste-567614287905114.jpg"" />"					"<img src=""tmplfxtkK.png""><br/>"	"<br/><img src=""Vitamin D (Calciferol) Biochemistry - OG copy.jpg""><img src=""Vitamin D (Calciferol) Biochemistry - OG.jpg""><br/>"		#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Biochemistry #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37854029956	<div>One source of <b>vitamin D</b> (cholecalciferol) is through <i>synthesis</i> from <b>7-dehydrocholesterol</b> in the presence of <b>{{c1::UV light}}</b></div>	"<img src=""paste-567614287905114.jpg"" />"					"<img src=""tmplfxtkK.png""><br/>"	"<br/><img src=""Vitamin D (Calciferol) Biochemistry - OG copy.jpg""><img src=""Vitamin D (Calciferol) Biochemistry - OG.jpg""><br/>"		#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Biochemistry #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37854007012	<div><b>Cholecalciferol</b> is converted to {{c1::<b>25-hydroxycholecalciferol</b> (25-OH-cholecalciferol)}} in the <b>{{c2::liver}}</b>; this compound is chemically <b>{{c3::inactive}}</b> </div>	"Importantly, this is done by liver <b>CYP450 enzymes</b>, thus patients taking cytochrome p450 inducers / inhibitors should adjust their intake of vitamin D accordingly<br /><div><br /></div><div><img src=""paste-584875761467748.jpg"" /></div>"					"<img src=""tmplfxtkK.png""><br/>"	"<br/><img src=""Vitamin D (Calciferol) Biochemistry - OG copy.jpg""><img src=""Vitamin D (Calciferol) Biochemistry - OG.jpg""><br/>"		#AK_Step1::#B&B::MSK::03_Pathology::01_Bone_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Biochemistry #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::^NBME120
-37853988116	<div>In the <b>{{c4::kidney}}</b>, 25-hydroxycholecalciferol may be hydroxylated by the enzyme <b><i>{{c1::1α-hydroxylase}}</i></b> to produce <b>{{c2::1,25-dihydroxycholecalciferol}}</b>; this compound is chemically <b>{{c3::active}}</b> </div>	"<div><i>1,25-dihydroxycholecalciferol is also known as 1,25-(OH)<sub>2</sub> **or calcitriol</i></div><div><i><img src=""paste-567614287905114.jpg"" /></i></div>"					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::$AnKingUpdates::Temporary #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853945298	<div>In the <b>kidney</b>, 25-hydroxycholecalciferol may be hydroxylated to produce <b>{{c1::24,25-dihydroxycholecalciferol}}</b>; this compound is chemically <b>{{c2::inactive}}</b> </div>	"<img src=""paste-567614287905114.jpg"" />"					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853931520	<div>The activity of the renal enzyme <b>1α-hydroxylase</b> is <b>increased</b> with {{c1::decreased}} serum<b> Ca<sup>2+</sup> </b>concentration</div>	"<div><i>thus there is more active vitamin D [1,25(OH<sub>2</sub>)]</i></div><div><img src=""paste-567614287905114.jpg"" /></div>"					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853907751	<div>The activity of the renal enzyme <b>1α-hydroxylase</b> is <u>increased</u> with {{c1::increased}}<b> PTH</b> levels</div>	"<div><i>thus there is more active vitamin D [1,25(OH<sub>2</sub>)]</i></div><div><img src=""paste-567614287905114.jpg"" /></div>"					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853893591	<div>The activity of the renal enzyme <b>1α-hydroxylase</b> is <u>increased</u> with {{c1::decreased}} serum <b>phosphate</b> concentration</div>	"<div><i>thus there is more active vitamin D [1,25(OH<sub>2</sub>)]</i></div><div><img src=""paste-567618582872410.jpg"" /></div>"					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853879858	<div>The role of <b>vitamin D</b> (cholecalciferol) is to <u>increase</u> <i>both</i> <b>{{c2::Ca<sup>2+</sup>}}</b> and <b>{{c2::phosphate}}</b> plasma concentrations to promote {{c1::<b>bone</b> <b>mineralization</b>}}</div>						"<img src=""tmplfxtkK.png""><br/>"	"<br/><img src=""Vitamin D (Calciferol) Biochemistry - OG copy.jpg""><img src=""Vitamin D (Calciferol) Biochemistry - OG.jpg""><br/>"		#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Biochemistry #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853830766	<div><b>1,25-dihydroxycholecalciferol</b> increases&nbsp;<b>{{c1::intestinal}}</b> <b>absorption</b> of Ca<sup>2+</sup> through synthesis of <b>calbindin D-28K</b></div>	"<div><i>PTH therefore <u>indirectly</u> increases intestinal Ca<sup>2+</sup> absorption by increasing the amount of 1,25-(OH)<sub>2</sub> </i></div><div><i><img src=""paste-567824741302594.jpg"" /></i></div>"					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853809278	<div>In addition to <u>calcium</u>, <b>1,25-(OH)<sub>2</sub> D<sub>3 </sub></b>also increases the <b>intestinal absorption</b> of <b>{{c1::phosphate (PO<sub>4</sub><sup>3-</sup>)}}</b></div>						"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853795444	<div>Similar to its action on the <u>intestines</u>, <b>1,25-dihydroxycholecalciferol</b> increases the <b>{{c1::renal}} reabsorption</b> of <b>Ca</b><sup><b>2</b>+</sup> and <b>phosphate</b> </div>						"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853767319	<div>In <i>bone</i>, <b>1,25-(OH)<sub>2</sub> D<sub>3</sub> </b>acts syngergistically with PTH to stimulate <b>{{c1::osteoclast}} activity</b> and <b>bone {{c1::resorption}}</b> </div>	"<i>which provides calcium and phosphate from ""old"" bone to mineralize ""new"" bone</i> "					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#B&B::Endocrinology::05_Other_Topics::02_Parathyroid_Glands #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853755845	<div>What effect does <b>1,25-dihydroxycholecalciferol</b> have on its <i>own </i><b>production</b>?</div><div><br /></div><div>{{c1::Inhibits it (negative feedback)}}</div>						"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853722960	<div><div>In <b>children</b>, vitamin D deficiency causes <b>{{c1::rickets}}</b></div></div>	"<i>characterized by growth failure and skeletal deformities</i> <div><i> <br> </i></div>  <div><i>**children that are exclusively <span data-markjs=""true"" class=""amboss-mark amboss-mark-single"" data-phrase-id=""lzXvG00"" data-phrase-term=""breast"" id=""mark-6"">breast</span> fed are at increased risk</i></div> "					"<img src=""tmplfxtkK.png""><br/>"	"<br><img src=""Vitamin D (Calciferol) Deficiency & Excess - OG copy.jpg""><img src=""Vitamin D (Calciferol) Deficiency & Excess - OG.jpg""><br>"		#AK_Step1::#B&B::MSK::03_Pathology::01_Bone_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::#Physeo::Biochemistry::Metabolism::S20.11-Vitamin_D #AK_Step1::#Pixorize::Biochem::Vitamins::D_Deficiency_&_Excess #AK_Step1::#SketchyPath::MSK_&_Derm::(1)Bone::1.2_Osteomalacia_&_Rickets #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853711485	<div><div>In <b>adults</b>, vitamin D deficiency causes <b>{{c1::osteomalacia}}</b> </div></div>	<i>characterized in bending and softening of weight bearing bones</i> 					"<img src=""tmpibpBde.png""><div><img src=""paste-a90cd09c86e61769e29ccba2ed92fc0537412e42.jpg""></div>"			#AK_Step1::#B&B::MSK::03_Pathology::01_Bone_Disorders #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37853702085	<div><b>Vitamin D resistance</b> most commonly occurs due to <b>{{c1::chronic renal failure}}</b></div>	<i>may also occur due to congenital absence of 1α-hydroxylase</i>					"<img src=""tmplfxtkK.png""><br/>"			#AK_Step1::#B&B::Renal::04_Diseases_Nephron::06_Renal_Failure #AK_Step1::#FirstAid::endo::phys::parathyroid::vitd #AK_Step1::Endocrine::Costanzo::10_Reg_Ca_&_P_Metab #AK_Step1::Endocrine::Physiology
-37795478357	<b>Pituitary </b>{{c1::<b>adenoma</b>}} is a <i>benign</i> tumor of the <b>anterior pituitary cells</b>						"<img src=""tmpnLKKUU.png""><br/>"	"<img src=""paste-63273458205689.jpg"" /><br/><img src=""tmpHKVrCg.png"">"	"<b>Atlas:</b><br> <img src=""tmpSvq3Zx.png""><br/><img src=""tmpdHEbSf.png""><br/>"	#AK_Step1::#B&B::Neurology::07_Other::07_Brain_Tumors #AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793899568	<div><b>Pituitary adenomas</b> may be <b>{{c1::functional}}</b> (hormone producing) or <b>{{c1::nonfunctional}}</b> (silent)</div>	If functioning, results in hyper----emia of whatever the hormone cell tumor produces (ex lactotroph --&gt; hyperprolactinemia)					"<img src=""tmpnLKKUU.png""><br/>"	"<img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"	"<b>Atlas:</b><br> <img src=""tmpSvq3Zx.png""><br/><img src=""tmpdHEbSf.png""><br/>"	#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit
-37793892781	<div><b>Nonfunctional pituitary adenomas</b> present with symptoms due to <b>{{c1::mass effect}}</b></div>						"<img src=""tmpnLKKUU.png""><br/>"	"<img src=""tmpBeCR65.png"" />"	"<b>Atlas:</b><br> <img src=""tmpSvq3Zx.png""><br/><img src=""tmpdHEbSf.png""><br/>"	#AK_Step1::#B&B::Neurology::07_Other::07_Brain_Tumors #AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793886661	<div><b>Pituitary adenoma</b> may present with <b>{{c1::bitemporal hemianopsia}}</b> due to compression of the <b>{{c2::optic chiasm}}</b> </div>	"<div><i>tumor sits in sella turcica, which is adjacent to optic chiasm, these patients will present with a history of <b>clumsiness</b> and <b>visual changes</b></i></div><div><i><br /></i></div><div><i><img src=""paste-21513491186253.jpg"" /></i></div>"					"<img src=""tmpnLKKUU.png""><br/>"	"<div><i><img src=""paste-63733019706361.jpg""></i><br></div><img src=""tmpHKVrCg.png"">"	"<b>Atlas:</b><br> <img src=""tmpSvq3Zx.png""><br/><img src=""tmpdHEbSf.png""><br/>"	#AK_Step1::#B&B::Neurology::07_Other::07_Brain_Tumors #AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37793846487	<div><b>Pituitary adenoma</b> may present with <b>{{c1::hypopituitarism}}</b> due to compression of normal pituitary tissue</div>						"<img src=""tmpnLKKUU.png""><br/>"	"<img src=""paste-63277753172985.jpg"" /><br/><img src=""tmpHKVrCg.png"">"	"<b>Atlas:</b><br> <img src=""tmpSvq3Zx.png""><br/><img src=""tmpdHEbSf.png""><br/>"	#AK_Step1::#B&B::Neurology::07_Other::07_Brain_Tumors #AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793837090	<div>A <i>non-specific</i> symptom of <b>pituitary adenoma</b> is {{c1::headache}} (due to mass effect)</div>						"<img src=""tmpnLKKUU.png""><br/>"	"<img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png""><br>"	"<b>Atlas:</b><br> <img src=""tmpSvq3Zx.png""><br/><img src=""tmpdHEbSf.png""><br/>"	#AK_Step1::#B&B::Neurology::07_Other::07_Brain_Tumors #AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793831094	<div>What is the <u>most common</u> type of <i>functional</i> <b>pituitary adenoma</b>? </div><div><br /></div><div>{{c1::Prolactinoma}}</div>						"<img src=""tmpnLKKUU.png""><br/>"	"<img src=""paste-87265145521145.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#B&B::Neurology::07_Other::07_Brain_Tumors #AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::prolactinoma #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793826605	<div>In <u>females</u>, <b>prolactinoma</b> presents as <b>{{c1::galactorrhea}}</b> and <b>{{c2::amenorrhea}}</b> </div>	<i>due to increased lactogenesis and decreased GnRH</i>					"<img src=""tmpnLKKUU.png""><br/>"	"<img src=""paste-88815628715001.jpg""><img src=""paste-132843338466345.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#B&B::Endocrinology::04_Reproductive::04_Menstrual_Cycle #AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::prolactinoma #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793814449	<div>In <u>males</u>, <b>prolactinoma</b> presents as <b>headache</b>, <b>decreased {{c1::libido}},</b> and <b>infertility</b></div>	"<i>due to inhibition of GnRH release and mass effect; no galactorrhea</i><div><i><br /></i></div><div><i>HOWEVER, men with prolactinomas are more likely to present at an advanced stage with mass-effect symptoms<br /></i><div><i><br /></i></div><div><i><img src=""paste-25529285607425.jpg"" /></i></div></div>"					"<img src=""tmpnLKKUU.png""><br/>"	"<div><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png""><i><img src=""paste-88978837472249.jpg""></i><br></div>"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::prolactinoma #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37793773668	<div><b>Prolactinoma</b> may be treated with a <b>{{c1::dopamine}} <i>agonist</i></b>, such as <b>{{c1::bromocriptine}}</b> or <b>{{c2::cabergoline}}</b></div>	<i>also may be treated with surgical removal of the tumor</i>					"<img src=""tmpnLKKUU.png"" /><br />"	"<img src=""paste-88016764797945.jpg""><img src=""paste-88124138980345.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png""><img src=""paste-132972187485225.jpg"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::prolactinoma #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793742180	<div><b>Growth hormone cell adenoma</b> presents as <b>{{c1::gigantism}}</b> in <b>{{c2::children}}</b> due to increased linear bone growth</div>						"<img src=""tmp89w3nY.png"">"	"<img src=""paste-89013197210617.jpg"" /><img src=""tmpBeCR65.png"" />"		#AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793730898	<div><b>Growth hormone cell adenoma</b> presents as <b>{{c1::acromegaly}}</b> in <b>{{c2::adults}}</b> </div>						"<img src=""tmp89w3nY.png"">"	"<img src=""paste-89069031785465.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"	"<img src=""big_56e2d556d090e.jpg""><div><br></div><div><div><div>Acromegalic facies</div></div><div><div><div>There is significant enlargement of the nose, chin, supraorbital region, lips, and zygomatic arch. The prominent lower jaw is particularly striking (prognathism).</div></div></div></div><div><br></div><div><img src=""big_58cbcfd6ea063.jpg""><br></div><div><div><div>Hand in acromegaly</div></div><div><div><div>Photograph of a left hand of a male acromegaly patient (right side) with the hand of a healthy person (roughly same age and height) for comparison (left side)</div><div>The hand of the patient is visibly enlarged and the fingers are widened.</div></div></div></div><div><br></div><div><img src=""big_56d04fb606ab0.jpg""><br></div><div><br></div><div><div><div>Enlarged forehead in acromegaly</div></div><div><div><div>Forehead of a patient with acromegaly that is noticeably enlarged, particularly in the right supraorbital region. This is a characteristic feature of acromegaly.</div></div></div></div><div><img src=""big_56d050ef7c0db.jpg""><br></div><div><br></div><div><div><div>Spacing of teeth in acromegaly</div></div><div><div><div>Pronounced gaps can be seen between the incisors in the lower row of teeth. This is caused by abnormal jaw growth, which has pushed the teeth apart. The gaps between the teeth are a characteristic finding in patients with acromegaly.</div></div></div></div><br/>"	#AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793719826	<div><b>Acromegaly</b> is characterized by a <b>large {{c1::tongue}}</b> with <b>deep furrows</b> and a deep voice </div>						"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-89133456294905.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793709753	<div><b>Acromegaly</b> causes enlarged bones in the <b>{{c1::hands}}</b>, <b>{{c1::feet}}</b>, and <b>{{c1::jaw}}</b> </div>						"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-90374701843449.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793684578	<div><b>Acromegaly</b> may cause growth of <b>visceral {{c1::organs}}</b>, leading to dysfunction </div>						"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-89309549954041.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793675571	<div><b>Acromegaly</b> causes impaired <b>{{c1::glucose}}</b> tolerance (i.e. insulin resistance), which may present as secondary <b>{{c1::diabetes mellitus}}</b> </div>						"<img src=""tmp89w3nY.png""><br/>"	"<br /><img src=""paste-89769111454713.jpg"" />"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793659319	<div><b>Acromegaly</b> is associated with increased <b>{{c1::insulin}} resistance</b> </div><div></div>	"<i>thus contributing to secondary diabetes mellitus</i><div><div><div><div><i><img src=""paste-10146971905949697.jpg""></i></div></div><div style=""font-weight: bold;""><div><i><br></i></div></div></div><div><b><img src=""paste-13078175416323.jpg""><img src=""acro.png""></b></div></div>"					"<img src=""tmp89w3nY.png""><br/>"	"<br><img src=""paste-90490665960441.jpg"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::im::ome::endo::anterior_pit
-37793620961	<div>What is the <u>most common</u> cause of death in patients with <b>acromegaly</b>? </div><div><br /></div><div>{{c1::Heart failure}}</div>						"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-89416924136441.jpg"" /><img src=""tmpBeCR65.png"" />"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793578207	<div><b>Growth hormone cell adenoma</b> may be diagnosed by elevated serum levels of <b>{{c1::growth hormone}}</b> and/or <b>{{c1::IGF-1}}</b> </div>						"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-88437671592953.jpg""><img src=""paste-90314572301305.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793563102	<div><b>Growth hormone cell adenoma </b>may be diagnosed by lack of <b>GH</b> <b>{{c1::suppression}}</b> by <b>oral glucose</b> </div>						"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-90486370993145.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793548208	<div>One possible treatment for a <b>growth hormone adenoma</b> is a <b>{{c1::somatostatin}} <i>analog</i></b>, such as <b>{{c1::octreotide}}</b> </div>	<i>somatostatin suppresses GH release; may also surgically remove the adenoma</i>					"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-90602335110137.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793532833	<div>One possible treatment for a <b>growth hormone adenoma</b> is a <b>{{c1::GH receptor <i>antagonist</i>}}</b>, such as <b>{{c2::pegvisomant}}</b></div>	<i>may also surgically remove the adenoma </i>					"<img src=""tmp89w3nY.png""><br/>"	"<img src=""paste-90598040142841.jpg""><img src=""tmpBeCR65.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::adenoma::gh::acromegaly #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793464757	<b>TSH</b> cell, <b>LH</b>-producing, and <b>FSH</b>-producing <b>adenomas</b> occur, but are <b>{{c1::rare}}</b> (frequency)						"<img src=""tmpnLKKUU.png"">"	"<img src=""paste-91671781966841.jpg""><img src=""paste-6e67f4b0e02d5deadf8c94b1cba20d6258064637.png"">"		#AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37793463258	<b>{{c1::Hypopituitarism}}</b> is the insufficient production of hormones by the <b>anterior pituitary gland</b>						"<img src=""tmpJgcZlG.png""><br/>"	"<br/><img src=""tmpp8BPWT.png"">"		#AK_Step1::#B&B::Endocrinology::05_Other_Topics::01_Pituitary_Gland #AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792586657	<div>Symptoms of <b>hypopituitarism</b> arise when &gt;<b>{{c1::75}}</b>% of the pituitary parenchyma is lost</div>						"<img src=""tmpJgcZlG.png""><br/>"	"<br/><img src=""tmpp8BPWT.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::general #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792581208	<div>One possible cause of <b>hypopituitarism</b> in adults is {{c1::pituitary adenoma}} (due to <b>mass effect</b>)</div>						"<img src=""tmpJgcZlG.png""><br/>"	"<br/><img src=""tmpp8BPWT.png"">"		#AK_Step1::#B&B::Neurology::07_Other::07_Brain_Tumors #AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::pituitaryadenoma #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792570138	<div>One possible cause of <b>hypopituitarism</b> in <b>children</b> is {{c1::craniopharyngioma}} (due to <b>mass effect</b>) </div>						"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-64385854735353.jpg"" /><img src=""paste-64574833296377.jpg"" /><br/><img src=""tmpHKVrCg.png""><img src=""craniopharyngioma.jpeg"">"	"<b>Atlas:</b><br> <img src=""paste-1954227299549810.png"" />"	#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::craniopharyngioma #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Pixorize::Biochem::Neurological_Disorders::Craniopharyngioma #AK_Step1::Endocrine::Pathology
-37792564759	<div>One possible cause of <b>hypopituitarism</b> is a <b>{{c1::pituitary apoplexy}}</b>, which is a <b>sudden</b> <b>{{c2::hemorrhage}}</b> of the pituitary gland, often in the presence of an existing adenoma</div>						"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-63874753627129.jpg"" /><br/><img src=""tmpHKVrCg.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::apopplexy #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792552096	<div><b>Hypopituitarism</b> may be caused by <b>{{c1::Sheehan}} syndrome</b>, which is a <b>{{c2::pregnancy}}-related {{c3::infarction}}</b> of the pituitary gland </div>	- pregnancy induced growth of pituitary (estrogen stimulates hyperplasia of lactotrophs), as well as the minimal vascularity of the pituitary gland, make the pituitary susceptible to hypoperfusion<div><br /></div><div>- therefore, heavy postpartum bleeding will manifest with hypoperfusion of the kidney</div>					"<img src=""tmpJgcZlG.png""><br/>"	"<div><img src=""paste-65073049502713.jpg""><img src=""paste-65163243815929.jpg""><img src=""paste-65313567671289.jpg""></div><img src=""tmpHKVrCg.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::sheehan #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37792525424	<div>During <b>pregnancy</b>, the size of the <b>pituitary</b> <b>gland</b> <b>{{c1::doubles}}</b>, but blood supply does not increase significantly </div>	<i>thus increased risk of infarction (<b>Sheehan syndrome</b>)</i>					"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-65158948848633.jpg""><br><img src=""tmpHKVrCg.png"">"	"<i><img src=""ed sheehan.png""></i>"	#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::sheehan #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::obgyn::uw #AK_Step2::Zanki_Step_2::ObGyn::Pregnancy,_Childbirth_&_Puerperium
-37792459195	<div>Pregnancy-related infarction of the pituitary gland (<b>Sheehan syndrome</b>) often occurs following <b>{{c1::postpartum bleeding}}</b></div>	<i>blood loss increases risk of infarction</i>					"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-65317862638585.jpg""><br><img src=""tmpHKVrCg.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::sheehan #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792433880	<div>Symptoms of <b>Sheehan syndrome</b> include poor<b> {{c1::lactation}}</b>, loss of <b>{{c1::pubic hair}}</b>, and <b>fatigue</b></div>	"<i>also may have </i><b style=""font-style: italic; "">absent menstruation</b><i> and </i><b style=""font-style: italic; "">cold intolerance</b> "					"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-65566970741753.jpg""><img src=""paste-65476776428537.jpg""><br><img src=""tmpHKVrCg.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::sheehan #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792407982	<div><i>External</i> causes of <b>hypopituitarism</b> include<b> {{c1::brain injury}}</b> and <b>{{c2::radiation}}</b> </div>						"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-63200443761657.jpg"" /><br/><img src=""tmpHKVrCg.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::other #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792398839	<div><b>Hypopituitarism</b> may be caused by <b>{{c1::empty sella}} syndrome</b>, which may occur due to trauma or congenital defect of the sella</div>						"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-66301410149369.jpg"" /><img src=""paste-66494683677689.jpg"" /><br/><img src=""tmpHKVrCg.png"">"	"<b>Atlas:</b><br> <img src=""tmpgQjI4L.png""><br/>"	#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::emptysella #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792385920	<div><b>Empty sella syndrome</b> occurs due to atrophy or compression, and ultimately destruction of the <b>{{c1::pituitary}} gland</b></div>	<i>for example, herniation of the arachnoid and CSF into the sella</i>					"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-66498978644985.jpg""><img src=""paste-66297115182073.jpg""><br><img src=""tmpHKVrCg.png"">"	"<b>Atlas:</b><br> <img src=""tmpgQjI4L.png""><br/>"	#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::emptysella #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792285459	<div><b>Empty sella syndrome</b> is characterized by {{c1::absence}} of the <b>pituitary gland</b> on imaging</div>						"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-66297115182073.jpg"" /><br/><img src=""tmpHKVrCg.png"">"	"<b>Atlas:</b><br> <img src=""tmpgQjI4L.png""><br/>"	#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::emptysella #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792276889	<div>What demographic is more commonly affected by <b>empty sella syndrome</b>? </div><div><br /></div><div>{{c1::Obese women}}</div>						"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""paste-66597762892793.jpg"" /><br/><img src=""tmpHKVrCg.png"">"	"<b>Atlas:</b><br> <img src=""tmpgQjI4L.png""><br/>"	#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::emptysella #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37792274341	What is the treatment for <b>hypopituitarism</b>?<div><br /></div><div>{{c1::Hormone replacement therapy}}</div>	<i>e.g. corticosteroids, thyroxine, sex steroids, human growth hormone</i>					"<img src=""tmpJgcZlG.png""><br/>"	"<img src=""tmpp8BPWT.png"">"		#AK_Step1::#FirstAid::endo::path::pituitary::anterior::hypopituitarism::treatment #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37791663687	<b><i>{{c1::Central}}</i> diabetes insipidus</b> is characterized by <b>polyuria</b> and <b>polydipsia</b> with an <u>inability</u> to <b>{{c3::concentrate}}</b> urine due to<b> {{c2::<u>lack of ADH</u>}}</b> 						"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-77064598193263.jpg"" /><img src=""paste-77266461656175.jpg"" /><img src=""paste-77365245903983.jpg"" /><br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37790171415	<b><i>{{c1::Nephrogenic}}</i> diabetes insipidus</b> is characterized by <b>polyuria</b> and <b>polydipsia</b> with an <u>inability</u> to <b>{{c3::concentrate}}</b> urine due to<b> {{c2::lack of <u>response</u> to ADH}}</b>						"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-77060303225967.jpg"" /><img src=""paste-77270756623471.jpg"" /><img src=""paste-77369540871279.jpg"" /><br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37790144965	<div>Etiologies of <b><i>{{c1::central}}</i> diabetes insipidus</b> include pituitary tumor, autoimmune, trauma, surgery, and ischemic encephalopathy </div>	- Autoimmune can be against posterior pituitary or against ADH<div><br /></div><div>- Trauma can be neurosurgery (9% of cases), head injury (17% of cases - ex. basilar skull fracture)</div><div><br /></div><div>- Benign Suprasellar tumor (20% of cases) / trauma to posterior pituitary / pituitary stalk / head trauma depletes posterior pituitary of ADH stores</div><div><br /></div><div>- noninfectious granulomas (sarcoidosis, langerhans cell histiocytosis)</div><div><br /></div><div>- idiopathic (25% of cases)</div><div><br /></div><div>- hemochromatosis</div><div><br /></div><div>- genetic mutation (AD mutation in neurophysin II- carrier for ADH as it descends the neurohypophysis)</div>					"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-77571404334191.jpg""><img src=""paste-77592879170671.jpg""><img src=""paste-77622943941743.jpg""><br><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld #AK_Step1::^EXPN::^NBME120
-37790138223	<div><b><i>{{c2::Nephrogenic}}</i> diabetes insipidus</b> is often caused by <b>{{c1::ADH receptor}}</b> <b>mutations</b> </div>						"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-76690936038511.jpg"" /><img src=""paste-78211354461295.jpg"" /><br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37790122642	<div><b><i>{{c1::Nephrogenic}}</i> diabetes insipidus</b> may be caused by drugs such as <b>{{c2::lithium}}</b> and <b>{{c3::demeclocycline}}</b> </div>	<i>demeclocycline is an ADH antagonist</i>					"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-77691663418479.jpg""><br><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37790101061	"<div>Both <i style=""font-weight: bold; "">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by <b>urine specific gravity </b>&lt; {{c1::1.006}}</div>"						"<img src=""tmpjcm2Tr.png""><br/>"	"<br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::labs #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789978480	"<div>Both <i style=""font-weight: bold; "">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by {{c1::low}} <b>urine osmolality</b></div>"						"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-77060303225967.jpg"" /><br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::labs #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789969465	"<div>Both <i style=""font-weight: bold; "">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by <b>serum osmolality</b> {{c1::&gt;}} 290 mOsm/kg</div>"	<i>due to decreased ability to retain H<sub>2</sub>O</i> 					"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-77313706296431.jpg""><br><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::labs #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789949886	"<div>Both <i style=""font-weight: bold; "">central</i> and <b><i>nephrogenic</i> diabetes insipidus</b> are characterized by blood <b><i>hyperosmotic</i> volume {{c1::contraction}}</b></div>"	<i>lack of ADH causes excess water excretion and thus volume contraction</i>					"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-705b73a15d31617743ba3fa33633b1b967209622.jpg""><br>"		#AK_Step1::#B&B::Renal::03_Electrolytes::01_Electrolyte_Disorders #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789888406	<div><b><i>Central</i> diabetes insipidus</b> is characterized by {{c1::low}} levels of <b>ADH</b></div>						"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-76905684403311.jpg"" /><br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789880052	<div><b><i>Nephrogenic </i>diabetes insipidus</b> is characterized by {{c1::normal}} or {{c1::elevated}} levels of <b>ADH</b></div>						"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-76794015253615.jpg"" /><br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::centralvsnephrogenic #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789871119	"<div>Treatment for <i style=""font-weight: bold; "">central</i><b> diabetes insipidus</b><i style=""font-weight: bold; ""> </i>includes <b>hydration</b> and <b>{{c1::desmopressin}}</b>, which is an <b>ADH</b> <i>analog</i></div>"						"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-78486232368239.jpg"" /><img src=""paste-78507707204719.jpg"" /><br/><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Hematology::01_Hemostasis::04_Coagulopathies #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::treatment #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789818086	<div>Treatment for <b><i>nephrogenic</i> diabetes insipidus</b> includes <b>hydration</b> and <b>{{c1::HCTZ}}</b>, which is a <b>thiazide</b> <b>diuretic</b></div>	<i>may also use <b>indomethacin</b> and <b>amiloride</b> </i>					"<img src=""tmpjcm2Tr.png""><br/>"			#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::treatment #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789816149	<div>Diagnosis of <b>diabetes insipidus</b> is aided by the <b>{{c1::water deprivation}} test</b> </div>	"<img src=""Water deprivation testing.png"" />"					"<img src=""tmpjcm2Tr.png""><br/>"	"<img src=""paste-78280073938031.jpg""><br><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::waterdeprivation #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789809239	<div>In <b>diabetes insipidus</b>, the <b>water deprivation test</b> <i>fails</i> to <b>{{c1::increase}}</b> urine osmolality</div>	"<i>**osmolality will increase in <b>central</b> diabetes insipidus with administration of an <b>ADH analog</b> </i><div><i><img src=""Water deprivation testing.png"" /></i></div>"					"<img src=""tmpjcm2Tr.png""><br/>"	"<div><i><img src=""paste-78353088382063.jpg""><img src=""paste-78378858185839.jpg""><img src=""paste-78305843741807.jpg""></i></div><div></div><div></div><img src=""tmpOkOhsC.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::diabetesinsipidus::waterdeprivation #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::#Physeo::Endocrinology::Physiology::S02_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789790793	<div>One possible cause of <b>SIADH</b> is <b>{{c1::small cell}} lung carcinoma</b>, which provides a source of <i>ectopic</i> ADH</div>						"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""paste-79572859094127.jpg"" /><br/><img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Pulmonary::03_Other::03_Lung_Cancer #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789754814	<div><b>Disease</b> of which <b>organ system</b> is most commonly associated with <b>SIADH</b>?</div><div><br></div><div>{{c1::Pulmonary}} </div>	<i>e.g ectopic SIADH from small cell carcinoma </i>					"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Pulmonary::03_Other::03_Lung_Cancer #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::im::uw::miscellaneous
-37789749382	"<div><b>SIADH</b> may be caused by drugs, such as<b> </b>(<i><b><font color=""#aa0000"">C</font></b>an't <b><font color=""#aa0000"">C</font></b>oncentrate <b><font color=""#aa0000"">S</font></b>erum Sodium)</i></div><div><i><br /></i></div><div><i>- <b><font color=""#aa0000"">C</font></b>{{c1::arbamazepine}}</i></div><div><i>- <b><font color=""#aa0000"">C</font></b>{{c2::yclophosphamide}}</i></div><div><i>- <font color=""#aa0000"" style=""font-weight: bold; "">S</font></i>{{c3::<i>SRI</i>}}</div>"						"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""paste-79658758440047.jpg"" /><img src=""paste-79680233276527.jpg"" /><br/><img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37789743961	<div><b>SIADH</b> is characterized by <i>increased</i> <b>{{c1::retention}}</b> of free <b>water</b></div><div><br /></div><div><b><br /></b></div>						"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""paste-7e950713282cc71bd96dd5baf43ef2c45a37a5e8.jpg""><br><img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::02_Sodium_Water_Balance #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789732982	<div><b>SIADH</b> is characterized by <b>{{c1::urine}} </b>osmolality &gt; <b>{{c1::serum}}</b> osmolality </div><div><br /></div><div><b><br /></b></div>						"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""paste-79246441579631.jpg"" /><img src=""paste-79336635892847.jpg"" /><br/><img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::02_Sodium_Water_Balance #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::$AnKingUpdates::Temporary #AK_Step1::Endocrine::Pathology
-37789719662	<div><b>SIADH</b> is characterized by <b>{{c1::euvolemic}}</b><b> </b>(volume) <b>{{c1::hyponatremia}}</b> (Na<sup>+</sup> level) with continued urinary Na<sup>+</sup> excretion</div>	<i>body responds to water retention with <b>decreased aldosterone</b>, causing normal volumes (euvolemic) but decreased sodium (hyponatremia)</i>					"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""paste-78920024065135.jpg""><img src=""paste-78868484457583.jpg""><br><img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Renal::03_Electrolytes::02_Sodium_Water_Balance #AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789613096	<div>The <i>very low</i> serum <b>Na<sup>+</sup></b> concentration in <b>SIADH</b> can lead to <b>{{c2::cerebral}} {{c1::edema}}</b> and <b>seizures</b> </div>						"<img src=""tmpdPxUK4.png"">"	"<img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789593380	<div>In <b>SIADH</b>, serum Na<sup>+</sup> levels must be corrected <b>slowly</b> to prevent <b>{{c1::osmotic demyelination}} syndrome</b> </div>	<i>formerly known as <b>central pontine myelinolysis</b></i>					"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""tmpMz6JXg.png"">"	"<b>Atlas:</b><br> <br/><img src=""tmpBGfSIA.png"">"	#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789583877	Treatment of <b>SIADH</b> includes <b>water restriction</b> and <b>{{c1::demeclocycline}}</b>, which is a<b> tetracycline</b>	<i>other treatments include IV hypertonic saline and <b>conivaptan</b>/<b>tolvaptan</b> (ADH receptor antagonists)</i>					"<img src=""tmpdPxUK4.png""><br/>"	"<img src=""paste-79890686674031.jpg""><br><img src=""tmpMz6JXg.png"">"		#AK_Step1::#B&B::Renal::03_Electrolytes::03_Sodium_Disorders #AK_Step1::#FirstAid::endo::path::pituitary::posterior::siadh #AK_Step1::#Pathoma::15_Endocrine::15.01-15.02-Anterior_&_Posterior_Pituitary_Gland #AK_Step1::Endocrine::Pathology
-37789513182	<div>A <b>{{c2::thyroglossal duct}} cyst</b> presents as an <b>{{c1::anterior, midline::location}}</b> <b>{{c3::neck}}</b> <b>mass</b> that moves with swallowing or protrusion of the tongue</div>	"<i>versus branchial cleft cyst in the lateral neck; may contain thyroid cells</i><div><br></div><div><div>The Thyroglossal duct may persist and result in a thyroglossal duct cyst (occuring in midline near hyoid bone or at the base of the tongue), thus will classically move up with swallowing or tongue protrusion</div></div><div><br></div><div><img src=""paste-57565446668289.jpg""><img src=""paste-61933428408321.jpg""></div>"					"<img src=""tmp15gu6e.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmp4vCcd5.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#FirstAid::endo::path::thyroid::embryology::thyroglossalductcyst #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37788823671	<div>The <b>thyroid</b> develops at the base of the tongue (primitive pharynx) and then travels along the <b>{{c1::thyroglossal}} duct</b> to the anterior neck <br></div><div><br></div><div><i>Bonus: forms from which arch?</i></div>	"<div><b>Thyroid diverticulum</b> develops in floor of embryonic pharynx <b>(1st arch) </b>at 3-4 weeks of gestation, thyroglossal duct progenitor migrates caudally and thyroid gland eventually assumes its normal position below larynx (unless interrupted) </div><div><img src=""paste-59296318488577.jpg"" /></div><div><img src=""paste-55538222104577 (1).jpg"" /></div>"					"<img src=""tmp15gu6e.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmp4vCcd5.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#FirstAid::endo::path::thyroid::embryology::thyroglossalductcyst #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::$AnKingUpdates::$Errata::bonus #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37788819441	<div>The <b>{{c1::foramen cecum}}</b> (of the tongue) is the <u>normal</u> <b>remnant</b> of the <b>thyroglossal</b> <b>duct</b> </div>	"site of thyroid primordium<div><img src=""paste-28668906701396.jpg"" /><div><img src=""paste-40699110096897.jpg"" /></div></div>"					"<img src=""tmp15gu6e.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmp4vCcd5.png""><br/><b>Netters:</b><br> <img src=""paste-147579371259276.png"" />"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#FirstAid::endo::path::thyroid::embryology::thyroglossalductcyst #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37788817096	<div>A <i>partially</i> involuted <b>thyroglossal</b> <b>duct</b> may present as a <b>{{c1::pyramidal}} lobe</b> on the thyroid </div><div><br /></div><div><b><br /></b></div>						"<img src=""tmp15gu6e.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmp4vCcd5.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#FirstAid::endo::path::thyroid::embryology::thyroglossalductcyst #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37788814904	<div><b>{{c1::Lingual thyroid}}</b> is the persistence of thyroid tissue at the <b>{{c2::base of the tongue}}</b> (due to failure of <u>migration</u>)</div>	"<i>thus, presents as a base of tongue mass </i><div><i><img src=""Thyroid migration 1.png"" /></i></div><div><i><img src=""Thyroid migration 2.png"" /></i></div>"					"<img src=""tmp15gu6e.png""><br/>"			#AK_Step1::#FirstAid::endo::path::thyroid::embryology::lingual #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37788807086	<div>What is the most common site for <b>ectopic thyroid tissue</b>?</div><div><br /></div><div>{{c1::The tongue}} </div>						"<img src=""tmp15gu6e.png""><br/>"			#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#FirstAid::endo::path::thyroid::embryology::lingual #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37781127780	<div>How does <u>hyperthyroidism</u> cause an <b>increased basal metabolic rate</b>?</div><div><br></div><div>{{c1::Via increased synthesis of Na<sup>+</sup>-K<sup>+</sup> ATPase pumps}}</div>						"<img src=""tmpPHaTki.png""><br/>"	"<img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780236862	<div>How does <b>hyperthyroidism</b> cause <u>increased</u><b> sympathetic nervous system </b>activity?</div><div><br /></div><div>{{c1::Increased expression of beta<sub>1</sub>-adrenergic receptors}} </div>						"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-409851549189176.jpg"" /><br/><img src=""tmpmhRZVS.png"">"		#AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780225199	<div>Which <b>thyroid imbalance</b> presents with <b><u>decreased</u> heat production</b> (<b>cold</b> <b>intolerance</b>) and <b><u>decreased</u> sweating</b>?</div><div><br></div><div>{{c1::Hypothyroidism}} </div>	Decreased BMR (due to decreased Na/K-ATPase activity) leads to decreased calorigenesis					"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-403731220792376.jpg""><br><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780217041	<div><div>Which <b>thyroid imbalance</b> presents with <b><u>increased</u> heat production</b> (<b>heat</b> <b>intolerance</b>) and <b>increased sweating</b>?</div><div><br></div><div>{{c1::hyperthyroidism}}</div></div><div><br></div><div><br></div>	Increased synthesis of Na/K-ATPase results in increased BMR --&gt; increased calorigenesis					"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-409679750497336.jpg""><br><img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::$AnKingUpdates::Temporary #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780209917	"<div>Which <b>thyroid imbalance</b> presents with <b>weight </b><u style=""font-weight: bold; "">loss</u> and <b>increased appetite</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div><div><br></div><div><div><br></div></div>"						"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-409675455530040.jpg"" /><br/><img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780204966	"<div><div>Which <b>thyroid imbalance</b> presents with <b>weight </b><u style=""font-weight: bold; "">gain</u> and <b>decreased appetite</b>?</div><div><br /></div><div>{{c1::hypothyroidism}}</div></div><div><br /></div><div><div><br /></div></div>"						"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-404225142031416.jpg"" /><br/><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780155779	<div><div>Which <b>thyroid imbalance</b> presents with <b>hyperdefecation / diarrhea</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div>	<i>increased GI motility</i>					"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-465647469331512.jpg""><br><img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780154423	<div><div>Which <b>thyroid imbalance</b> presents with <b>constipation</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>	<i>decreased GI motility</i>					"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-404362580984888.jpg""><br><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780143733	<div><div>Which <b>thyroid imbalance</b> presents with <b><u>decreased</u> reflexes</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>	"Reflexes are delayed / slow relaxing (""hung up reflexes"")"					"<img src=""tmpPHaTki.png""><br/>"	"\<img src=""paste-405891589342264.jpg""><br><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld #AK_Step1::^FA_Updates::FA2018
-37780140257	<div><div>Which <b>thyroid imbalance</b> presents with <b><u>increased</u> reflexes</b>?</div><div><br /></div><div>{{c1::hyperthyroidism}}</div></div>	Reflexes are brisk					"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-465535800181816.jpg""><br><img src=""tmpmhRZVS.png"">"		#AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780137216	<div><div>Which <b>thyroid imbalance</b> presents with <b>tachycardia</b>, <b>palpitations</b>, and <b>arrhythmias</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div>	<i>due to increased number and sensitivity of beta-adrenergic receptors</i><div><i><br /></i></div><div><i>can go into <b>atrial fibrillation</b></i></div>					"<img src=""tmpPHaTki.png""><br/>"	"<div><img src=""paste-465333936718904.jpg""></div><img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Cardiology::04_Arrhythmias::03_AFib_Flutter #AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::$AnKingUpdates::Temporary #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780123893	<div><div>Which <b>thyroid imbalance</b> presents with <b>bradycardia </b>and <b>dyspnea</b> <b>on exertion</b>?</div><div><br /></div><div>{{c1::hypothyroidism}}</div></div>						"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-405075545556024.jpg"" /><br/><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780120657	"<div><div>Which <b>thyroid imbalance</b> presents with <b>proximal muscle weakness</b> and <u style=""font-weight: bold;"">normal</u><b>&nbsp;creatine&nbsp;kinase</b>?</div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div>"	<i>thyrotoxic myopathy</i>					"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-409791419647032.jpg""><br><img src=""tmp_rbBLk.png"">"		#AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780105108	<div><div>Which <b>thyroid imbalance</b> presents with <b>proximal muscle weakness</b> and <b><u>increased</u>&nbsp;</b><b>creatine</b><b>&nbsp;kinase</b>?</div><div><br></div><div>{{c1::Hypothyroidism}}</div></div>	<i>hypothyroid myopathy; presents with weakness, cramps and myalgias</i><div><i><br /></i></div><div><i>increased serum CK common in up to 90%</i></div>					"<img src=""tmpPHaTki.png""><br/>"	"<div><img src=""paste-404538674644024.jpg""></div><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37780096416	<div>Does <b>hyperthyroidism</b> present with <b>hypo-</b> or <b>hyper-cholesterolemia</b>? Why?</div><div><br></div><div>{{c1::Hypocholesterolemia; due to <u>increased</u> LDL receptor expression}}</div><div><br></div><div><div><br></div></div>						"<img src=""tmpPHaTki.png""><br/>"	"<br/><img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780090437	<div><div>Does <b>hypothyroidism</b> present with <b>hypo-</b> or <b>hyper-cholesterolemia</b>? Why?</div><div><br /></div><div>{{c1::Hypercholesterolemia; due to <u>decreased</u> LDL receptor expression}}</div></div><div><br /></div><div><div><br /></div></div>						"<img src=""tmpPHaTki.png""><br/>"	"<img src=""paste-404293861508152.jpg"" /><br/><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780080299	<div><div>Does <b>hyperthyroidism</b> present with <b>hypo-</b> or <b>hyper-glycemia</b>? Why?</div><div><br /></div><div>{{c1::Hyperglycemia; due to increased gluconeogenesis and glycogenolysis}} </div></div><div><br /></div><div><br /></div>						"<img src=""tmpPHaTki.png""><br/>"	"<br/><img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypervshypo #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780074918	<div>What type of <b>hypersensitivity</b> is <b>Graves disease</b>?</div><div><br /></div><div>{{c1::Type II (antibody-mediated)}}</div>						"<img src=""tmp7h2x9S.png""><br/>"	"<img src=""paste-467266672002104.jpg"" />"	"<b>Atlas:</b><br> <img src=""tmpuHAplD.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::hyper::graves #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780067897	<div>What demographic is most commonly associated with <b>Graves disease</b>?</div><div><br /></div><div>{{c1::Women of childbearing age; often presents <u>during stress</u> (e.g. childbirth)}}</div>						"<img src=""tmp7h2x9S.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpuHAplD.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::hyper::graves #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780061195	<div>What <b>type</b> of <b>goiter</b> is associated with <b>Graves disease</b>?</div><div><br /></div><div>{{c1::Diffuse goiter}}</div><div><br /></div><div><b><br /></b></div>						"<img src=""tmp7h2x9S.png""><br/>"	"<div>Defusing the bomb</div><img src=""paste-489497422726200.jpg"">"	"<b>Atlas:</b><br> <img src=""tmpuHAplD.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::hyper::graves #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37780056279	<div><b>Graves disease </b>is associated with <b>{{c1::pretibial}} {{c2::myxedema}}</b> which occurs due to activation of <b>dermal {{c3::fibroblasts}}</b></div>	"<i>This is due to primarily <b>TRab</b> (and to a lesser degree T-cell lymphocyte) activation of fibroblasts, which deposit GAGs that are osmotic and draw in water (Non-pitting edema)</i><div><br /></div><div>this is typically only seen in graves and is <b>infrequent</b> (1-5% of cases)</div><div><br /></div><div><img src=""paste-66481798774785 (1).jpg"" /></div>"					"<img src=""tmp7h2x9S.png""><br/>"	"<div><img src=""paste-467816427815992.jpg""><br></div>"	"<b>Atlas:</b><br> <img src=""tmpuHAplD.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hyper::graves #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld #AK_Step1::^FA_Updates::FA2018
-37780038005	<div><div><b>Graves disease </b>is associated with<b> {{c1::exophthalmos}}</b> which occurs due to activation of <b>retro-orbital {{c2::fibroblasts}}</b></div></div>	"<div><div><i>- activated <b>T cells release cytokines (TNFa, IFN-y) </b>which activate fibroblasts (along with TRab to a lesser degree), causing increased secretions of <b>glycosaminoglycans</b></i></div></div><div><i><br /></i></div><div><i>- GAG deposition leads to osmotic muscle swelling, muscle inflammation, and increased adipocyte count --&gt; <b>eyes being pushed out</b>, dysfunction of extraocular muscles causes restricted extraocular movements and diplopia</i></div><div><i><br /></i></div><div><i><img src=""paste-32933809226028.jpg"" /></i></div><div><i>visible appearance causes appearance of a ""<b>stare</b>"" </i></div><div><i><br /></i></div><div><i><img src=""paste-20491288969217.jpg"" /></i></div>"					"<img src=""tmp7h2x9S.png""><br/>"	"<div><div><img src=""paste-467691873764408.jpg""><i><img src=""paste-467601679451192.jpg""></i></div></div>"	"<b>Atlas:</b><br> <img src=""tmpuHAplD.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hyper::graves #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld #AK_Step1::^FA_Updates::FA2018
-37779981278	<div><b>{{c1::Scalloped}} {{c2::colloid}}</b> is a characteristic <u>histological</u> finding associated with <b>{{c3::Graves disease}} </b></div>	"<div><i>""scallops"" are the white spaces adjacent to epithelium; also can observe <u>tall crowded follicular epithelium</u></i></div><div><i><u><br></u></i></div><div><img src=""paste-31009663877626.jpg""></div>"					"<img src=""tmp7h2x9S.png""><br/>"	"<div><img src=""paste-467872262390840.jpg""><br></div>"	"<b>Atlas:</b><br> <img src=""tmpuHAplD.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::hyper::graves #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37779834121	<div><b>{{c1::Thyroid storm (Thyrotoxicosis)}}</b> is a serious complication that occurs when <b>hyperthyroidism</b> is <u>untreatened</u> and <u>worsened</u> in the setting of <b>acute stress</b> (e.g. infection, trauma, surgery)</div>	patient has a preexisting hyperthyroid disease (grave's or toxic multinodular goiter)<div><br /></div><div>acute stress + hyperthyroidism leads to massive catecholamine surge --&gt; symptoms</div>					"<img src=""tmp7h2x9S.png"">"	"<div><img src=""paste-466098440897592.jpg""></div><img src=""tmp_rbBLk.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37779824217	<div><b>Thyroid storm</b> presents with agitation, delirium, fever, diarrhea, coma, and <b>{{c1::tachyarrhythmia}}</b> (cause of death) </div>						"<img src=""tmp7h2x9S.png""><br/>"	"<img src=""paste-466381908739128.jpg"" />"		#AK_Step1::#FirstAid::endo::path::thyroid::hyper::storm #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37779819385	<div>What serum marker may be elevated in <b>thyroid storm</b> due to increased <b>bone turnover</b>?</div><div><br /></div><div>{{c1::Alkaline phosphatase}}</div>	May also see increased <b>LFTs</b>					"<img src=""tmp7h2x9S.png""><br/>"			#AK_Step1::#FirstAid::endo::path::thyroid::hyper::storm #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37779814226	"<div>What are the ""<b>4 P's</b>"" used to treat <b>thyroid storm</b>?</div><div><br /></div><div> 1. {{c1::<b>P</b>ropranolol}} (a beta-blocker)</div><div> 2. {{c1::<b>P</b>ropylthiouracil}} </div><div> 3. {{c2::<b>P</b>rednisolone}} (a corticosteroid)</div><div> 4. {{c2::<b>P</b>otassium iodide}} (Lugol iodine)  </div>"						"<img src=""tmp7h2x9S.png""><br/>"	"<img src=""paste-76b17a36882d00f39564e2499c20376e7866f9d6.jpg""><div><img src=""paste-400108b08a4806993f54cdb485ce132e7928d2c5.jpg""></div><div><img src=""paste-a3604aea63dfa358befb5f0d23eb39c4b94029cb.jpg""></div><div><img src=""paste-0a36f46702ca0d19cd6a28f73a89bc9b927fcbe8.jpg""></div><div><img src=""paste-67186afde3a63a2640c0fa6ad3433ae2c3252063.jpg""></div><div><img src=""paste-81b2b4f35bd082d63c73acca6e2bedb66822b9d7.jpg""><br><div><br></div></div>"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hyper::storm #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37779783263	<div><b>{{c1::Multinodular goiter}}</b> is an <b>enlarged</b> thyroid gland with <b>multiple</b> <b>nodules</b></div>	"<div><i>often due to relative iodine deficiency and usually nontoxic (euthyroid)</i></div><div><i><img src=""paste-31284541784593.jpg"" /></i></div>"					"<img src=""tmp7h2x9S.png""><br/>"	"<div><i><img src=""paste-490231862133816.jpg""></i><br></div><div></div><img src=""tmpwdTSwU.png"">"	"<b>Atlas:</b><br> <img src=""tmpQtoN2Y.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::hyper::multinodular #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37779768932	<div>A <b>{{c1::toxic}} multinodular goiter</b> occurs when a multinodular goiter has <b>hyperfunctioning follicular cells</b> that work <u>independently</u> of <b>TSH</b>, causing increased release of T<sub>3</sub> and T<sub>4</sub> </div>	"<div><i>Note follicles of various sizes distended with colloid (black arrows) and lined by flattened epithelium with areas of fibrosis and hemorrhage (blue arrows)</i></div><div><img src=""paste-32950989095332.jpg"" /></div>"					"<img src=""tmp7h2x9S.png""><br/>"	"<div><img src=""paste-468271694349368.jpg""><br></div><img src=""tmp_rbBLk.png"">"	"<b>Atlas:</b><br> <img src=""tmpQtoN2Y.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::hyper::multinodular #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37779723331	<div><b>Toxic multinodular goiter</b> is most often due to <b>{{c1::TSH receptor}} mutations</b> (60% of cases) </div>						"<img src=""tmp7h2x9S.png""><br/>"	"<img src=""paste-468357593695288.jpg"" /><br/><img src=""tmp_rbBLk.png"">"	"<b>Atlas:</b><br> <img src=""tmpQtoN2Y.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hyper::multinodular #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37779714821	<div>The <b>{{c1::Jod-Basedow}} phenomenon</b> describes <b>{{c3::thyrotoxicosis (hyperthyroidism)}}</b> in a patient with <b>iodine</b> <b>deficiency</b> who is made <b>iodine</b> <b>replete</b></div><div><i><br /></i></div>	<i>opposite of the Wolff-Chaikoff effect; excess I<sub>2</sub> increases thyroid hormone secretion</i>					"<img src=""tmp7h2x9S.png""><br/>"			#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hyper::jodbasedow #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37779672530	<div><b>{{c1::Hypothyroidism}}</b> in neonates and infants is known as <b>cretinism</b> </div>						"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-405337538561080.jpg"" /><br/><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776284436	<div>A <b>p</b>ot-bellied, <b>p</b>ale, <b>p</b>uffy-faced child with <u><b>p</b>rotruding umbilicus</u>, <b>p</b>rotuberant tongue, and <u><b>p</b>oor brain development</u> is characteristic of <b>{{c1::cretinism}}</b> </div>	"<img src=""paste-37439229919316.jpg"" /><div><img src=""paste-21182778704290.jpg"" /><img src=""paste-21195663606039.jpg"" /></div>"					"<img src=""tmpd37f9_.png""><br/>"	"<div><img src=""paste-405406258037816.jpg""></div>"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::01_Thyroid_Gland #AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776236876	<div>One cause of <b>cretinism</b> is <b>{{c1::dyshormonogenetic goiter}}</b>, which is due to a congenital defect in thyroid hormone production</div>						"<img src=""tmpd37f9_.png""><br/>"		"<img src=""paste-635037bdd8b51ef263fcd4534e80a196decad703.jpg""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776227776	<div><b>Dyshormonogenetic goiter</b> (congenital defect in thyroid hormone production) most commonly involves a <b>{{c1::thyroid peroxidase}}</b> <b>deficiency</b> </div>						"<img src=""tmpd37f9_.png""><br/>"			#AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776218733	<div>The most common cause of <b>cretinism</b> in the <u>U.S.</u> is <b>{{c1::thyroid dysgenesis}}</b></div>	<i>other causes include:</i><div><div><i>- antibody mediated maternal hypothyroidism</i></div><div><i>- thyroid agenesis (NOT the same as thyroid dysgenesis)</i></div></div>					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-405432027841592.jpg""><i><br></i><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37776206856	<div><div><b>{{c2::Myxedema}}</b> is the accumulation of <b>{{c1::glycosaminoglycans}}</b> in the skin and soft tissue; it is most often associated with <b>{{c3::hypothyroidism}}</b> </div></div>	"the major GAG is hyaluronic acid, which then draws water out into the deposit (in interstitial spaces of the dermis; due to osmotic pressure) and causes swelling (water retention; usually facial / periorbital swelling but can be <u>generalized nonpitting edema</u>)<div><br /></div><div>a myxedema coma = coma from hypothyroidism</div><div><br /></div><div><img src=""paste-42563125903361.jpg"" /></div>"					"<img src=""tmpd37f9_.png""><br/>"	"<div><img src=""paste-403937379222584.jpg""><img src=""paste-406411280385080.jpg""><br></div><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37776197845	<div><div>In <b>hypothyroidism</b> patients, <b>myxedema</b> </div><div>commonly affects the <b>{{c1::larynx}}</b> (causing deep voice) and <b>{{c1::tongue}}</b> (causing enlargement)</div></div>						"<img src=""tmpd37f9_.png""><br/>"	"<img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776190785	<div><div>Which <b>thyroid imbalance</b> is associated with <b>dry, cool skin</b> and <b>coarse, brittle hair</b>?</div></div><div><br></div><div>{{c1::Hypothyroidism}}</div><div><br></div><div><div><div><br></div></div></div>	- Dry and cool skin is due to decreased blood flow to dermal blood vessels					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-404676113597496.jpg""><br><img src=""tmpR1z3nU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37776187845	<div><div><div>Which <b>thyroid imbalance</b> is associated with <b>warm, moist skin</b> and <b>fine hair</b>?</div></div><div><br></div><div>{{c1::Hyperthyroidism}}</div></div><div><br></div><div><b><br></b></div>	- warm and moist skin is due to increased blood flow to dermal blood vessels					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""tmpmhRZVS.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::cretinism #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::$AnKingUpdates::Temporary #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37776185358	<div><b>Hashimoto thyroiditis</b> is associated with <b>HLA-{{c1::DR3}}</b> and <b>HLA-{{c1::DR5}}</b></div>						"<img src=""tmpd37f9_.png"">"	"<img src=""tmp7EAGiu.png"">"	"<br/><img src=""paste-b91946dde82629f4236caf5086f72f17d45a20da.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776180179	<div>What is the most common cause of <b>hypothyroidism</b> in regions where iodine levels are adequate?</div><div><br /></div><div>{{c1::Hashimoto thyroiditis}}</div>	"<i>other causes include:</i><div><i>- <b>iodine</b> <b>deficiency </b>(<b>Endemic Goiter </b> - especially in Southeast Asia and Africa)</i></div><div><i>- <b>Wolff-Chaikoff effect</b> (iodine excess)</i></div><div><i>- goitrogens (e.g. lithium, amiodarone)</i></div><div><i><br /></i></div><div><i>iodine deficiency shown below</i></div><div><i><img src=""paste-154034707103745.jpg"" /></i></div>"					"<img src=""tmpd37f9_.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpoumuL6.png""><br/><br/><img src=""paste-b91946dde82629f4236caf5086f72f17d45a20da.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::hashimoto #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37776153205	<div><i>Initially</i>, <b>Hashimoto thyroiditis</b> presents as <b>{{c1::hyperthyroidism}} </b>due to thyrotoxicosis during follicular rupture </div>	<i>ultimately progresses to <b>hypothyroidism</b> (decreased T<sub>4</sub>, increased TSH)</i>					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""tmpR1z3nU.png"">"	"<b>Atlas:</b><br> <img src=""tmpoumuL6.png""><br/><br/><img src=""paste-b91946dde82629f4236caf5086f72f17d45a20da.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::hashimoto #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776137195	<div>Which <u>two</u> antibodies are associated with <b>Hashimoto thyroiditis</b>? </div><div><br></div><div>{{c1::Anti-thyroglobulin}} and {{c2::anti-thyroid peroxidase (anti-microsomal)}} </div>	<i>these are a <b>sign</b> of thyroid damage, not the <b>cause</b> of damage</i><div><i><br></i></div><div><i>Note: anti-mito<b>chondrial</b>&nbsp;(primary biliary cholangitis) vs anti-micro<b>somal</b>&nbsp;(Hashimoto)</i></div>					"<img src=""tmpd37f9_.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpoumuL6.png""><br/><br/><img src=""paste-b91946dde82629f4236caf5086f72f17d45a20da.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::basic::immunology::immuneresponse::autoantibodies #AK_Step1::#FirstAid::endo::path::thyroid::hypo::hashimoto #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37776108270	<div><u>Histologically</u>, <b>Hashimoto thyroiditis</b> is associated with <b>chronic inflammation</b> with well-developed <b>{{c1::germinal centers}}</b></div>	"This is an <b>autoimmune disorder, </b>T-cells attack thyroid, B-cells get activated<br /><div><br /></div><div><img src=""paste-36614596198925.jpg"" /></div>"					"<img src=""tmpd37f9_.png""><br/>"		"<b>Atlas:</b><br> <img src=""tmpoumuL6.png""><br/><br/><img src=""paste-b91946dde82629f4236caf5086f72f17d45a20da.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::hashimoto #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37776099082	<div><u>Histologically</u>, <b>Hashimoto thyroiditis</b> may have <b>{{c1::Hurthle}} cells</b>, which are <b>eosinophilic</b> metaplastic cells that line the follicles</div><div></div>	"<img src=""paste-36614596198925.jpg"" />"					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-409280318538808.jpg""><br><img src=""tmp7EAGiu.png"">"	"<b>Atlas:</b><br> <img src=""tmpoumuL6.png""><br/><br/><img src=""paste-f460bfc939c60f1c90e01e630d150b4ee0077d04.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::hashimoto #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776083589	<div>Patients with <b>Hashimoto thyroiditis</b> have an increased risk for <b>{{c1::B-cell (marginal zone) lymphoma}}</b>; presents as an enlarging thyroid late in disease course</div>						"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-409306088342584.jpg""><br><img src=""tmp7EAGiu.png"">"	"<b>Atlas:</b><br> <img src=""tmpoumuL6.png""><br/><br/><img src=""paste-32f1a4172d03db9334fe7bd0acb3c25eac2abca5.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Hematology::03_WBCs::04_Non_Hodgkin_Lymphoma #AK_Step1::#FirstAid::endo::path::thyroid::hypo::hashimoto #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37776075882	<div>Does <b>Hashimoto thyroiditis</b> present with a <b>tender</b> or <b>nontender</b> thyroid?</div><div><br /></div><div>{{c1::Nontender}}</div>	<i>and mildly enlarged</i>					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-409112814814264.jpg""><br><img src=""tmp7EAGiu.png"">"	"<img src=""paste-827734687219713.jpg""><img src=""paste-5942074369114113.jpg""><div><b>Atlas:</b><br> <img src=""tmpoumuL6.png""><br></div><br><img src=""paste-32f1a4172d03db9334fe7bd0acb3c25eac2abca5.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::hashimoto #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::peds::nbme
-37776066893	<div><b>Subacute granulomatous thyroiditis (de Quervain)</b> is a self-limited disease often following <b>{{c1::viral infection}}</b></div>						"<img src=""tmpd37f9_.png""><br/>"	"<div><img src=""paste-492748712969272.jpg"" /></div><img src=""paste-492538259571768.jpg"" /><br/><img src=""tmpwdTSwU.png"">"	"<div><b>Subacute&nbsp;</b>= after an ""acute"" process (viral)</div><div><b>Self-limited&nbsp;</b>=&nbsp;hyper → hypothyroid</div><div><br></div><img class="""" src=""paste-833928030060545.jpg"" style=""height: 379px; width: 551px;""><div><img class="""" src=""paste-3485434680180737.jpg"" style=""height: 230px; width: 299px;""></div><br/><b>Atlas:</b><br> <img src=""tmp5HWWOH.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::subacute #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::fam::exam_guru
-37776046747	<div>Does <b>subacute granulomatous thyroiditis (de Quervain)</b> present with a <b>tender</b> or <b>nontender</b> thyroid?</div><div><br /></div><div>{{c1::**Very tender**}}</div>	"<i>- may also have <b>jaw pain, </b>pain that radiates to <u>ears</u>, and elevated ESR / CRP</i><div><i><br /></i></div><div><i>- de Quer<font color=""#aa0000""><b>vain</b></font> is associated with <b><font color=""#aa0000"">pain</font></b></i></div>"					"<img src=""tmpd37f9_.png""><br/>"	"<div><img src=""paste-492924806628408.jpg""></div><img src=""tmpwdTSwU.png"">"	"<img src=""paste-d3d9d28e6029d28be300bce17a2ac6331d1c08f4.jpg""><br/><b>Atlas:</b><br> <img src=""tmp5HWWOH.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::subacute #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37776009279	<div><b>Subacute granulomatous thyroiditis (de Quervain)</b> may <i>initially</i> present with <b>{{c1::hyperthyroidism}}</b>, which typically is followed by a brief <b>{{c1::hypothyroid}}</b> state</div>	- Thyroid symptoms usually mild; this is permanent in ~15% of cases<div><br /></div><div>- during the transient hyperthyroid phase, radioiodine uptake is decreased due to low TSH levels</div>					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-493186799633464.jpg""><br><img src=""tmpwdTSwU.png"">"	"<b>Atlas:</b><br> <img src=""tmp5HWWOH.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::subacute #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^FA_Updates::FA2018
-37775998658	<div>What <u>histological</u> findings are associated with <b>Subacute thyroiditis (de Quervain)</b>?</div><div><br></div><div>{{c1::Granulomatous inflammation}}</div><div></div>	"<div>- SGT is initially characterized by a more neutrophilic infiltrate with microabscess formation; then replaced by a more generalized inflammatory infiltrate with macrophages and multinucleated giant cells</div><div><img src=""paste-96172907692527.jpg""><br></div>"					"<img src=""tmpd37f9_.png""><br/>"	"<div><img src=""paste-492533964604472.jpg""></div><img src=""tmpwdTSwU.png"">"	"<b>Atlas:</b><br> <img src=""tmp5HWWOH.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::subacute #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37775961309	<div><b>Riedel thyroiditis</b> is characterized by replacement of thyroid by <b>{{c1::fibrous}} tissue</b> with <b>inflammatory infiltrate</b></div>	"<img src=""paste-38646115729723.jpg"" />"					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-491095150560312.jpg""><img src=""paste-491000661279800.jpg""><img src=""paste-490880402195512.jpg""><br><img src=""tmpwdTSwU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::riedel #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37775923266	<div>In <b>Riedel thyroiditis</b>, fibrosis may extend to {{c1::<b>local structures</b> (e.g. airway)}}, thus mimicking <b>{{c2::anaplastic carcinoma}} </b></div>	<i>distinguishing feature is age (anaplastic carcinoma occurs in older patients)</i>					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-490936236770360.jpg""><br><img src=""tmpwdTSwU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::hypo::riedel #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37775893726	"<div><b>Riedel thyroiditis</b> presents as a ""<b>{{c1::hard as wood}}</b>"", <b>{{c2::nontender}}</b> (tender or non-tender) goiter</div>"						"<img src=""tmpd37f9_.png"">"	"<img src=""paste-491773755393080.jpg"" /><br/><img src=""tmpwdTSwU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37775880100	<div>What demographic is most commonly affected by <b>Riedel thyroiditis</b>?</div><div><br /></div><div>{{c1::Middled-aged women (30-50 years old)}}</div>	<i>important distinguishing feature versus anaplastic carcinoma** </i>					"<img src=""tmpd37f9_.png""><br/>"	"<img src=""paste-492224726959160.jpg""><br><img src=""tmpwdTSwU.png"">"		#AK_Step1::#FirstAid::endo::path::thyroid::hypo::riedel #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37775865821	<b>Riedel thyroiditis</b> is considered a manifestation of <b>{{c1::IgG<sub>4</sub>}}-related systemic disease</b>, which includes autoimmune pancreatitis, retroperitoneal fibrosis, and noninfectious aortitis 						"<img src=""tmpd37f9_.png""><br/>"	"<div><img src=""paste-491241179448376.jpg"" /></div><img src=""paste-54159537604442.jpg"" /><br/><img src=""tmpwdTSwU.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::hypo::riedel #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37775858435	<b>Thyroid nodules</b> are more likely to be <b>{{c1::benign}}</b> than <b>{{c1::malignant}}</b> (benign or malignant) 						"<img src=""tmpHgw63P.png"">"	"<br/><img src=""tmpBmu1R9.png"">"	"<img src=""paste-5fb879c99a073643f163ee400d7dcd7c9df1eeb3.jpg""><img src=""big_58ac80cb7082d.jpg""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771517676	<div><b>Thyroid nodules</b> may be studied using <b>{{c1::<sup>131</sup>I}} radioactive uptake studies</b> </div>						"<img src=""tmpHgw63P.png""><br/>"	"<br/><img src=""tmpBmu1R9.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::nodule #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771502132	<div>If a <b>thyroid nodule</b> has <b><u>increased</u></b> <b>uptake</b> of <b><sup>131</sup>I</b>, it is considered a <b>{{c1::hot}} nodule</b>; seen in Graves disease or nodular goiter</div>						"<img src=""tmpHgw63P.png""><br/>"	"<div><img src=""paste-468675421275192.jpg"" /></div><img src=""paste-468585226961976.jpg"" />"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::nodule #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771488876	<div>If a <b>thyroid nodule</b> has <b><u>decreased</u></b> <b>uptake</b> of <b><sup>131</sup>I</b>, it is considered a <b>{{c1::'cold'}} nodule</b></div>	<i>indicative of adenoma or carcinoma</i>					"<img src=""tmpHgw63P.png""><br/>"	"<div><img src=""paste-993b5731b7d6d6197cab64ea946d8d8b352793bf.jpg""><i><br></i><img src=""tmpBmu1R9.png""></div>"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::nodule #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771478110	<div>What is a <b>'cold' nodule</b> on <b><sup>131</sup>I radioactive uptake studies</b> indicative of?</div><div><br /></div><div>{{c1::Adenoma or carcinoma; warrants further biopsy}}</div>						"<img src=""tmpHgw63P.png""><br/>"	"<br/><img src=""tmpBmu1R9.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::nodule #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771468943	<div>How is a <b>biopsy</b> performed for a <b>thyroid nodule</b>? </div><div><br /></div><div>{{c1::Fine needle aspiration (FNA)}}</div>	<i>must do FNA because thyroid is highly vascularized</i>					"<img src=""tmpHgw63P.png""><br/>"	"<img src=""tmpBmu1R9.png"">"		#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::nodule #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771453375	<div><b>Thyroid {{c1::adenoma}}</b> is a <b>benign</b> solitary growth of the thyroid</div>						"<img src=""tmpHgw63P.png""><br/>"	"<br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <br/><img src=""tmpMAip6z.png""><br/><img src=""tmpWkbG_U.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::adenoma #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771445778	"<div>Most <b>thyroid adenomas</b> are <b>nonfunctional</b> (""cold""), but may rarely cause <b>{{c1::hyperthyroidism}}</b> via autonomous thyroid hormone production (""hot"" or ""toxic"") </div>"						"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-468769910555704.jpg"" /><br/><img src=""tmp_rbBLk.png"">"	"<b>Atlas:</b><br> <br/><img src=""tmpMAip6z.png""><br/><img src=""tmpWkbG_U.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::02_Thyroid_Disorders #AK_Step1::#FirstAid::endo::path::thyroid::tumor::adenoma #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771421824	<div>The most common type of <b>thyroid <u>adenoma</u></b> is <b>{{c1::follicular}} adenoma</b></div>						"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-272438365520933.jpg"" /><br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <br/><img src=""tmpMAip6z.png""><br/><img src=""tmpWkbG_U.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::adenoma #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771405032	<div>What is the main <u>distinguishing feature</u> between <b>follicular adenoma</b> and <b>follicular carcinoma</b> of the thyroid?</div><div><br /></div><div>{{c1::Follicular <u>adenoma</u> has a lack of capsular and vascular invasion}}</div>						"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-274323856163877.jpg"" /><br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <br/><img src=""tmpMAip6z.png""><br/><img src=""tmpWkbG_U.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::adenoma #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771370722	<div>Thyroid <b>follicular adenoma</b> is a benign tumor of follicles surrounded by a <b>{{c1::fibrous capsule}}</b></div>	"<div><i>usually nonfunctional; rarely may secrete thyroid hormone</i></div><div><img src=""paste-39049842655754.jpg"" /></div><div><i>note the tumor is separated by a dense, fibrous capsule </i></div>"					"<img src=""tmpHgw63P.png""><br/>"	"<div><img src=""paste-272571509507109.jpg""><br></div><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <br/><img src=""tmpMAip6z.png""><br/><img src=""tmpWkbG_U.png"">"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::adenoma #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771338401	<div>What is the <u>most common</u> type of <b>thyroid carcinoma</b>? </div><div><br /></div><div>{{c1::Papillary Carcinoma (80%)}}</div><div><br /></div>						"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-272932286759973.jpg"" /><br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771334339	<div>Exposure to {{c1::<b>ionizing</b> <b>radiation</b>}} in <b>childhood</b> is a major risk factor for thyroid <b>{{c2::papillary}} carcinoma</b> </div><div><br /></div>						"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-273052545844261.jpg"" /><br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771324175	<div>What <u>two</u> gene mutations are associated with increased risk of thyroid <b>papillary carcinoma</b>?</div><div><br /></div><div>{{c1::RET and BRAF}}</div>						"<img src=""tmpHgw63P.png"">"	"<img src=""paste-273396143227941.jpg""><br><img src=""tmpBmu1R9.png""><div><img src=""paste-0b713ce081cbb4d044577b77004db272c57f0aac.jpg""><br></div>"		#AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771305162	<div>Thyroid <b>{{c1::papillary}} carcinoma</b> may be lined by cells with clear, '<b>{{c2::Orphan Annie eye}}</b>' nuclei</div>	"<div><i>nuclei with central clearing, sometimes described as ""ground glass"" nuclei</i></div><div><img src=""paste-40235253629211.jpg"" /></div>"					"<img src=""tmpHgw63P.png""><br/>"	"<div><img src=""paste-273812755055653.jpg""><br></div><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-17771305162	<div>Thyroid <b>{{c1::papillary}} carcinoma</b> may be lined by cells with clear '<b>{{c2::Orphan Annie eye}}</b>' nuclei</div>	"<div><i>nuclei with central clearing, sometimes described as ""ground glass"" nuclei</i></div><div><img src=""paste-40235253629211.jpg"" /></div>"					"<img src=""tmpHgw63P.png""><br/>"	"<div><img src=""paste-273812755055653.jpg""><br></div><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-27771305162	<div>Thyroid <b>{{c1::papillary}} carcinoma</b> may be lined by cells with clear <b>{{c2::Orphan Annie eye}}</b> nuclei</div>	"<div><i>nuclei with central clearing, sometimes described as ""ground glass"" nuclei</i></div><div><img src=""paste-40235253629211.jpg"" /></div>"					"<img src=""tmpHgw63P.png""><br/>"	"<div><img src=""paste-273812755055653.jpg""><br></div><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771074946	<div>In addition to 'Orphan Annie eye' nuclei, thyroid <b>papillary carcinoma</b> may have cells with <b>intranuclear {{c1::grooves}} </b>and <b>inclusions</b></div>	"<img src=""paste-42799349104890.jpg"" /><div><img src=""paste-60352880443393.jpg"" /></div>"					"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-273817050022949.jpg""><br><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-17771074946	<div>In addition to Orphan Annie eye nuclei, thyroid <b>papillary carcinoma</b> may have cells with <b>intranuclear {{c1::grooves}} </b>and <b>inclusions</b></div>	"<img src=""paste-42799349104890.jpg"" /><div><img src=""paste-60352880443393.jpg"" /></div>"					"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-273817050022949.jpg""><br><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step1::^EXPN::BGedit #AK_Step1::^EXPN::Uworld
-37771031325	<div>Thyroid <b>{{c2::papillary}} carcinoma</b> may have <b>{{c1::psammoma}} bodies</b> on biopsy, which are characterized by <b>concentric</b> layers of <b>calcification</b> </div>	"<img src=""paste-39092792328714.jpg"" />"					"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-273696790938661.jpg""><br><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771019418	<div>Thyroid <b>papillary</b> <b>carcinoma</b> often spreads to the <b>{{c1::cervical}}</b> <b>nodes</b> (lymphatic invasion) </div>						"<img src=""tmpHgw63P.png""><br/>"	"<br/><img src=""tmpBmu1R9.png"">"	"<img src=""paste-db723abdb73d5bd6f20928e1906e402918649cd5.jpg""><div><img src=""big_5a202daa8821d.jpg""><img src=""5a202daa8821d.jpg""><br></div><div><div><div>Papillary thyroid carcinoma</div></div><div><div><div>Micrograph image of thyroid tissue (H&amp;E stain, 400x magnification)</div><div>Green overlay: psammoma bodies<br>White overlay: connective tissue core of papillae<br>Black outline: epithelial cancer cells covering the papillae</div></div></div></div><div><br></div><br/><b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771011455	<div>What is the prognosis of thyroid <b>papillary carcinoma</b>? </div><div><br /></div><div>{{c1::excellent}}</div><div><br /></div><div><br /></div>						"<img src=""tmpHgw63P.png""><br/>"	"<br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpW7blMi.png""><br/><img src=""tmpGmQqX7.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::papillary #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37771007492	<div>Thyroid <b>follicular carcinoma</b> is characterized by a malignant proliferation of follicles surrounded by a <b>{{c1::fibrous capsule}}</b> with <b>{{c1::invasion through the capsule}}</b></div>						"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-274319561196581.jpg"" /><br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpFYkIFm.png""><br/><img src=""tmp1DjObx.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::follicular #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37770982960	<div>Can <b>fine needle aspiration</b> distinguish between thyroid <b>follicular adenoma</b> versus <b>carcinoma</b>?</div><div><br /></div><div>{{c1::No; the fibrous capsule cannot be visualized with FNA}}</div>	"<img src=""paste-39225936314888.jpg"" />"					"<img src=""tmpHgw63P.png""><br/>"	"<img src=""tmpBmu1R9.png"">"	"<div>Even if capsule&nbsp;<u>doesn't</u>&nbsp;completely surround follicle (carcinoma) we can't see this with just a thin slice</div><div><br></div><div><img class="""" src=""paste-3667176221310977.jpg"" style=""height: 236px; width: 447px;""></div><div><img class="""" src=""paste-3629024026820609.jpg"" style=""height: 303px; width: 422px;""><img class="""" src=""paste-3773961993191425.jpg"" style=""height: 323px; width: 405px;""></div><br/><b>Atlas:</b><br> <img src=""tmpFYkIFm.png""><br/><img src=""tmp1DjObx.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::follicular #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::im::ome::endo::thyroid_nodules #AK_Step2::Dorian::surg::emma
-37770967818	<div>What <b>mutation</b> is thyroid <b>follicular carcinoma</b> associated with?</div><div><br /></div><div><i>{{c1::RAS}}</i></div>						"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-274173532308517.jpg"" /><br/><img src=""tmpBmu1R9.png"">"	"<b>Atlas:</b><br> <img src=""tmpFYkIFm.png""><br/><img src=""tmp1DjObx.png""><br/>"	#AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::follicular #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology
-37770960701	<div>What is the most common route of <b>metastasis</b> for a thyroid <b>follicular carcinoma</b>?</div><div><br /></div><div>{{c1::hematogenous}} </div>	This is one of the exceptions (carcinomas typically spread through lymphatics)					"<img src=""tmpHgw63P.png""><br/>"	"<img src=""paste-274319561196581.jpg"" /><br/><img src=""tmpBmu1R9.png"">"	"<b><img src=""paste-185654256336897.jpg""></b><br/><b>Atlas:</b><br> <img src=""tmpFYkIFm.png""><br/><img src=""tmp1DjObx.png""><br/>"	#AK_Step1::#B&B::Endocrinology::01_Thyroid::03_Thyroid_Cancer #AK_Step1::#FirstAid::endo::path::thyroid::tumor::carcinoma::follicular #AK_Step1::#Pathoma::15_Endocrine::15.03-15.07-Thyroid #AK_Step1::Endocrine::Pathology #AK_Step2::Dorian::surg::emma
